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Figure 1-1. Flow chart of the inclusion of articles 
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Gregg et al. 2007 Y U Y U Y N Y 4
Jung et al. 2015 Y N Y N U Y Y 4
Schroevers et al. 2015 Y Y U Y Y Y Y 6
Friis et al. 2016 Y Y U Y Y Y N 5
Khashouei et al. 2016 U U U U U Y Y 2
Shayeghian et al. 2016 Y U U Y Y Y Y 5
Domain´s total Ys 8 4 3 6 7 8 8
Note . Y = yes (low risk of bias)N = no (high risk of bias)U = unclear (uncertain risk of bias)
6
Tovote et al. 2014
Tovote et al. 2015 Y Y Y Y Y Y U 6
Y 2
van Son et al. 2013
van Son et al. 2014 Y Y U Y Y Y Y
Y Y 4
Miller et al. 2012
Miller et al. 2014 Y U U U U N
Hartmann et al. 2012
Kopf et al. 2014 U U U Y Y
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Table 1-2. Summary of included articles 







Outcomes of  MBIs vs. CON
pre to post effect Sizeg
Outcomes of MBIs vs. CON
pre to follow-up effect Sizeg









 (43 men, 38 women)
Mean age=50.9





Glucose level: HbA1c (0.34)
Hartmann et al. 2012









 (86 men, 24 women)
Mean age=59.01
8 weekly group sessions 16 .98% Glucose level: HbA1c (-0.14)
at 1-year follow-up
Glucose level: HbA1c (0.49)
van Son et al. 2013








 (70 men, 69 women)
Mean age=56.50
8 weekly group sessions
 (120 minutes) 25.71%
Glucose level: HbA1c (0.06)
Diabetes-related distress: PAID (0.20)
at 6-month follow-up
Glucose level: HbA1c (-0.02)
Diabetes-related distress: PAID (0.32)
Tovote et al. 2014












 (48 men, 46 women)
Mean age=53.1
8 weekly individual sessions
(45-60 minutes)
29% Glucose level: HbA1c (0.03)Diabetes-related distress: PAID (0.31) No data










(27 men, 29 women)
Mean age=66.27
8 weekly group sessions
 (60-120 minutes)
25% Glucose level: blood sugar (0.17)
Diabetes-related distress: DDS (0.22) No data





RCT with wait list
control codition MBCT
24 adults
 (14 men, 10 women)
Mean age=55.4
8 weekly individual sessions
(60 minutes)
17% Diabetes-related distress: PAID (1.27) No data





RCT with wait list
control codition MSC
63 adults
(20 men, 43 women)
Mean age=44.37
8 weekly group sessions
(150 minutes)
11.43% Glucose level: HbA1c (0.31)Diabetes-related distress: DDS (0.86)
at 3-month follow-up
Glucose level: HbA1c (0.65)
Diabetes-related distress: DDS (0.86)









 (40 men, 60 women)
Mean age=55.44
10-session ACT workshop and
diabetes education workshop
(120 minutes)
0% Glucose level: HbA1c (0.25)
at 3-month follow-up
Glucose level: HbA1c (0.27)
Note.  RCT: Randomized Controlled Trial, TAU: Treatment As Usual, ACT: Acceptance and Commitment Therapy, MBSR: Mindfulness Based Stress Reduction, MBCT: Mindfulness Based Cognitive Therapy,
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ɺȻǫ3űƧ4ʵProblem Areas In Diabetes SurveyʳPAID; Polonsky et al., 1995ʴ 3ȦʵDiabetes Distress 
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p<.01ʴ





ǾD&ʳHedges’g = 0.53, 95%Cl = 0.19 to 0.86, p < .01ʴ
0Aʵ¦ǐ.,ȟɏǯǦɨŖ4
ʟĵ1č.ǾD&ʳI 2 = 95%ʴ
MBSRʵMSC1*,4ä 1Ȧ3;-)&&=ʵtZɍƛ
Gěƈ-0)&ʵMBSR-4Ħ0ÒƜʈʳHedges’g = 0.22, 95%Cl = 0.06 to 0.38, p<.01ʴʵMSC-




Ɣ3ǇĚƍƔ4 3ƐŇ 1Ȧ 6ʵƐŇ 1Ȧ-)&
2Ȧ3ɟƅ1, MʵABIsȬ-£ǞD&
ŧƽ4 MʵBCT 1Ȧ MʵSC 1Ȧ-)&
Àƛ3ȞƜ ʵȅļ3ÒƜʈǾD&ʳ Hedges’g = 0.59, 
95%Cl = 0.06 to 1.12, p < .01ʴ
0AʵȟɏǯǦɨŖ4ʟĵ1č.ǾD&ʳI 2 = 98% 
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 ɂȕS_}{3űƧ-C HbA1cGIL_OsĊƃ1ɓĚ,Cɟƅ4 6Ȧ-)&
0ʵ
MABIsȬ1CƺǬʑēÌƔ3 HbA1c1*, Fʵriis, Johnson, Cutfield, & Consedineʳ 2016 -ʴ4 8.94ʲ





5Ȧ3ɟƅ1, MʵABIsȬ-£ǞD&ŧƽ4 AʵCT 1Ȧ MʵBCT 2Ȧʵ
MBSR 1ȦʵMSC 1Ȧ-)&
Àƛ3ȞƜʵÒƜʈ4ǾD0)&ʳHedges’g = 0.10, 95%Cl = -
0.06 to 0.26, p = n.s.ʴ





ʈ4ǾD0)&ʳHedges’g = 0.06, 95%Cl = -0.00 to 0.11, p < .10ʴ
0ʵȟɏǯǦɨŖ4Ħ.
ǾD&ʳI 2 = 0%ʴ
ACTʵMBSRʵMSC1*,4ä 1Ȧ3;-)&&=ʵtZɍƛGěƈ-
0)&ʵACT-4Ħ0ÒƜʈʳHedges’g = 0.25, 95%Cl = 0.18 to 0.32, p < .01ʴʵMBSR-4ÒƜʈ
ǾD!ʳ Hedges’g = -0.14, 95%Cl = -0.21 to -0.07, p < .01ʴʵ MSC-4Ħ0ÒƜʈǾD&ʳ Hedges’g 
= 0.31, 95%Cl = 0.19 to 0.43, p < .01ʴ
A1ʵiN}I\kƔ1C HbA1c3ſôÒƜ1*,ʵ
MABIs Ȭ.ȟÈȬ3ƴɰơɐGɃ)&
iN}I\kƔ3ǇĚƍƔ4 3 ƐŇ 3 Ȧʵ6 ƐŇ 1
Ȧʵ1ĸŇ 1Ȧ-)&
5Ȧ3ɟƅ1,ʵMABIsȬ-£ǞD&ŧƽ4ʵMBSR 1ȦʵMBCT
 1 ȦʵACT  2 ȦʵMSC  1 Ȧ-)&
Àƛ3ȞƜʵĦ0ÒƜʈǾD&ʳHedges’g = 0.35, 
95%Cl = 0.11 to 0.58, p < .01ʴ
0AʵȟɏǯǦɨŖ4ʟĵ1č.ǾD&ʳI 2 = 98% 
ʴ
$3&=ʵ£Ǟŧƽ»ɸ,& ACT 3 2 ȦGĢɣ.,TjQ{kɍƛGɃ)&
Àƛ3ȞƜʵ
Ħ0ÒƜʈǾDʵ3ƐŇ1,MABIsȬ-3ſôÒƜɚ=AD&ʳHedges’g = 0.38, 95%Cl 
= 0.32 to 0.45, p < .01ʴ
0ʵȟɏǯǦɨŖ4Ħ.ǾD&ʳI 2 = 15%ʴ
MBSRʵMBCTʵMSC
1*,4ä 1 Ȧ3;-)&&=ʵtZɍƛGěƈ-0)&ʵMBSR -4 1 ĸŇ1,ȅ
ļ3ÒƜʈʳHedges’g = 0.53, 95%Cl = 0.42 to 0.56, p < .01ʴʵMBCT-4 6ƐŇ1,ÒƜʈ4Ǿ
D!ʳHedges’g = -0.02, 95%Cl = -0.08 to 0.04, p = n.s.ʴʵMSC-4 3ƐŇ1,ȅļ3ÒƜʈǾ
D&ʳHedges’g = 0.53, 95%Cl = 0.37 to 0.52, p < .01ʴ
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 C.- HʵbA1c®3ſôɚ=AD&.ǾD,Cʳ Gregg et al. , 2007; Shayeghian, Hassanabadi, 





ºɅeKIW3ơɐ14 ǺʵȈƃ 10×ŐɈ-C.űŽC&=ʳ Higgins et al., 
2008ʴʵƗǺȈ-4ơɐ,0
Ȍ 2 1ʵMBSRʵMSC 1ʓ,ʵ£Ǟŧƽ1@CTjQ{kɍ
ƛGěƈ-0)&.C
MSC3 1Ȧ-4 ɂʵȕ®3ſôÒƜǾD,C MʵABIsʳ MSCʴ
ȬƺǬʑēÌƔ3 HbA1c ®4 8.94%.ʮ®-)&&=ʵ¸1@CÒƜŊAD? )&âȴŖ
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D,B 1ʵ÷3¸ƍʒƏč- 120À.ʎ ʵA1Ɖĵǝƿ3->ǵŚɑȨGɃŐɈ
C&=ʵȕĪǩŗȱ14ɤŭč)&.ȰADC
Ǖ1ʵvan Son et al.ʳ2013ʴ, Tovote et al.
ʳ2014ʴ, Jung, Lee, & Parkʳ2015ʴ -4ʵ`}\kIL_Ǚ 25%Gɪ,Bʵ`}\kIL_,
0ŗȱ->ʵƉĵǝƿ3-ǵŚɑȨGȠȡ-,A!ʵHbA1c ®3ſôɚ=AD0)&â
ȴŖC
Ƈ AʵCT3`}\kIL_Ǚ1*, Sʵhayeghian et al.ʳ 2016ʴ3`}\kIL_4ǰǎ
-BʵGregg et al.ʳ2007ʴ-4ʵǸƍʒ÷ęȞ3~PVx\kŃĿ-)&
0ʵACT4ʵ2ă
ȕĪǩċ1ʵČǭŖǻÕǪʳSheppard, Forsyth, Hickling, & Bianchi, 2010ʴʵǒʤǫʳDindo et al., 2012; 
Dindo et al., 2014ʴʵȲǈʳLillis, Hayes, Bunting, & Masuda, 2009ʴʵɂȑǨŗʳDindo, Marchman, Gindes, 
& Fiedorowicz., 2015aʴ1Ģ,ʵǸƍʒ÷ęȞ3~PVx\kŃĿ-ÒƜG,C.Ǿ
D,CʳDindo, 2015bʴ
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 Ȍ 11ʵȕĪǩƺǬ1ʓFC ACT3ɃÓǯk}XWGǇĚ C&=3űƧƄ³D,0.
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,ʵ
Acceptance and Action Diabetes QuestionnaireʳAADQ; Gregg et al., 2007ʴʑǭD,BʵAADQ3è
1@),ʵɂȕS_}{3ſôɚ=AD,CʳGregg et al., 2007; Shayeghian et al., 2016ʴ

0AʵAADQ 3ʑǭȝȧ1ʓ Cćë4ØÀ-BʵŏǛǇĚĘǯǕŖ14Ƌ0ǌČ.
















Figure 1-5. Behavior analytic model of eating behavior in diabetes patients 
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.ĚȭDCƤŔ-B Ɖʵĵǝƿ1CȔȁǪǖ
?ɮǪǖ3;0A!ʵǝǛǯ0űƧ0/3ɗ§G>ê<ĹƤŔ-CʳStone, & Shiffman, 1994ʴ
ł
Ãʵα.n1@CƉəƽǞAD,&ʵ3Ƈƽ14 fʵake compliance.í5DCƩǌűŽ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Figure 1-6. Conceptual model of EMA and questionnaires combination approach  




Figure 1-7. Conceptual model of treatment process optimization using Ecological Momentary Assessment 
Note. EMA = ecological momentary assessment 
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Figure 2-1. Outline of this study 
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 ȕĪǩƺǬ1œ0ŕȰ?Ŝř1Ģ CIPXkZWGǇĚ Cĩļ.,ʵAcceptance and 
Action Diabetes QuestionnaireʳAADQʴʑǭD,CʳGregg et al., 2007ʴ
0AʵGregg et al.
ʳ2007ʴ-4ʵAADQ 3ʑǭȝȧ1ʓ Cćë0ʵAADQ 3ŏǛǇĚĘǯǕŖ4Ƌ0ǌČ.
ťÄCʳO’Donohue et al., 2015ʴ
Gregg et al.ʳ2007ʴ3ÚǓ-4 1øĖ 11ʢǲ3ĩļ-)&
ʵSchmitt et al.ʳ2014ʴ-4ʵI-TǴʓÀƛ3ȞƜA 3ʢǲʵøĖÀƛ3ȞƜAČʆɤȽGǾ& 2
ʢǲGʗċ,B 1ʵøĖ 6ʢǲ-ƥš& AADQ¡šD&
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ʳ4ʴƉƗɛǓ Problem Areas in Diabetes ScaleʳPAID; ǹ, 1999ʴ 








ʳ5ʴƉƗɛǓ SF-8 Health SurveyʳSF-8; ȂÚʋʯ, 2005ʴ 
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ĖÀƛ-4ʵȌ 1øĖ3ĞǙ4 38.82ʲʳýƑ® 4.27ʴʵȌ 2øĖ3ĞǙ4 11.33ʲʳýƑ® 1.24ʴʵ
Ȍ 3øĖ3ĞǙ4 9.88ʲʳýƑ® 1.08ʴ.0),Bʵ1øĖʵ2øĖʵ3øĖ3!D3ɍʅ>âȴ
-CʵɍʅâȴŖ?ěǞŖGȰş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,ɍʅ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 ƉƗɛǓ AADQ3øĖƃ1*,ʵȌ 1øĖ3ĞǙ4 41.00ʲʳýƑ® 3.28ʴʵȌ 2øĖ3ĞǙ4
13.90ʲʳýƑ® 1.11ʴʵȌ 3øĖ3ĞǙ4 10.86ʲʳýƑ® 0.86ʴ.0),Bʵʢǲ 3.ʢǲ 6Gʗ
















 äɨóα3ķĂ.Ƨǉ°İG Table 3-3 1Ǿ 
ƉƗɛǓ AADQ .ũ*Ǫǖ1ʓ,4ʵCES-D .
3ʒ1ȅļ3ɤ3Ǵʓʳr = -.41, p < .01ʴGǾ&
ƉƗɛǓ AADQ.ȕĪǩʓɺȻǫ1ʓ,4ʵ
PAID.3ʒ1ȅļ3ɤ3Ǵʓʳr = -.44, p < .01ʴGǾ&
ƉƗɛǓ AADQ.X{iRIɃÓ1ʓ
,4ʵSDSCAȤå&ʩ.3ʒ1ŀƭ3Ǵʓʳr = .37ʵp < .01ʴʵSDSCAɽÓ.3ʒ1ŀ
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ƭ3Ǵʓʳr = .24ʵp < .01ʴǾD&
ƉƗɛǓ AADQ.ǝƿ3ɨ1ʓ,4ʵSF-8ɮǯTqz
WSI.3ʒ1ŀƭ3Ǵʓʳr = .29, p < .01ʴʵȔȁǯTqzWSI.3ʒ1ŀƭ3Ǵʓʳr 
= .32, p < .01ʴGǾ&
ƉƗɛǓ AADQ.ɂȕS_}{1ʓ,4 HʵbA1c.3ʒ1ŀɤ3Ǵʓ





AADQ GŉĭĊƃ., Welch ơĚGɃ0)&
$3ȞƜʵ1%Ʒǉ-Ƒśİ;AD&ʳƺǬȬ:ķĂ




 ƉƗɛǓ AADQ3½ǯƄåŖGơɐ&.E Cʵronbach3 α¨ƃ4 0.80-)&
:& ʢʵǲÞŒ




Table 3-1-1. Item Response Theory parameter estimates for the Japanese version of Acceptance and Action Diabetes 
  
a b 1 b 2 b 3 b 4 b 5 b 6
1 U4R=N+@3)&) 
[)&) 0.97 -2.86 -2.36 -1.87 -1.06 0.20 0.73
2 U4R=N);$9@%HD+D)b -0.76 1.76 1.31 0.11 -0.93 -1.53 -2.32
3 U4R=N+@3!R=NIO 1.00 -3.13 -2.65 -2.37 -1.92 -1.09 -0.62
4 \ $$\ HD
>E\ ! 0.87 -2.25 -1.65 -0.64 0.86 1.45 2.18
5 U4R=NM0HD%SK,	E*'+) 
CL&) 0.98 -2.76 -2.50 -1.73 -0.68 0.54 1.09
6 U4R=N+@3!V+]"^J<+)_+[(?*!() 0.91 -3.68 -3.05 -2.73 -2.02 -1.22 -0.64
7 \ 4)$+\ -./-+[(WL() 1.03 -2.44 -1.81 -1.27 -0.12 0.73 1.29
8 R=NY121B
)6TA+X#)8 1.14 -2.57 -2.11 -1.59 -0.87 0.08 0.66
9 U4R=N+@3!:FPZ5 0.72 -3.41 -2.49 -1.88 -1.19 0.04 0.52
10 R=NU4)S&) 0.89 -2.43 -1.60 -1.08 -0.41 0.61 1.05
11 R=NG,Q(7)R=NS&) 0.88 -3.53 -2.65 -2.44 -1.83 -0.48 0.14
Items
Item parameter estimatesa
   a Each of the b  parameters corresponds to a probability = 0.5 of choosing the response that is +1 from the subscript. The a  parameter is the slope at the location of all b parameters and corresponds to the item’s ability to
discriminate between individuals of different trait levels. b All items are reverse scored except Item 2.
 56 




a b 1 b 2 b 3 b 4 b 5 b 6
1 I try to avoid reminders of my diabetes. 0.97 -2.86 -2.36 -1.87 -1.06 0.20 0.73
2 I have thoughts and feelings about being diabetic that are distessing. b -0.76 1.76 1.31 0.11 -0.93 -1.53 -2.32
3 I do not take care of my diabetes because it reminds me that I have diabetes. 1.00 -3.13 -2.65 -2.37 -1.92 -1.09 -0.62
4 I eat things I shouldn't eat when the urge to eat them is overwhelming. 0.87 -2.25 -1.65 -0.64 0.86 1.45 2.18
5 When I have an upsetting feeling or thought about my diabetes, I try to get rid of that feeling or thought. 0.98 -2.76 -2.50 -1.73 -0.68 0.54 1.09
6 I avoid taking or forget to take my medication because it reminds me that I have diabetes. 0.91 -3.68 -3.05 -2.73 -2.02 -1.22 -0.64
7 I avoid stress or try to get rid of it by eating what I know I shouldn't eat. 1.03 -2.44 -1.81 -1.27 -0.12 0.73 1.29
8 I often deny to myself what diabetes can do to my body. 1.14 -2.57 -2.11 -1.59 -0.87 0.08 0.66
9 I don't exercise regulary because it reminds me that I have diabetes. 0.72 -3.41 -2.49 -1.88 -1.19 0.04 0.52
10 I avoid thinking about what diabetes can do to me. 0.89 -2.43 -1.60 -1.08 -0.41 0.61 1.05
11 I avoid thinking about diabetes because someone I knew died from diabetes. 0.88 -3.53 -2.65 -2.44 -1.83 -0.48 0.14
Items
Item parameter estimatesa
   a Each of the b  parameters corresponds to a probability = 0.5 of choosing the response that is +1 from the subscript. The a  parameter is the slope at the location of all b parameters and corresponds to the item’s ability to
discriminate between individuals of different trait levels. b All items are reverse scored except Item 2.
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Table 3-2-1. Result of confirmatory factor analysis of the Japanese version of Acceptance and Action Diabetes Questionnaire 
  
original 11-item version Schimmit's 6-item version  8-item version
1 U4R=N+@3)&) 
[)&) .64 .62 .58
2 U4R=N);$9@%HD+D)b -.44
3 U4R=N+@3!R=NIO .70 .77
4 \ $$\ HD
>E\ ! .44 .51
5 U4R=NM0HD%SK,	E*'+) 
CL&) .64 .61 .62
6 U4R=N+@3!V+]"^J<+)_+[(?*!() .67 .73
7 \ 4)$+\ -./-+[(WL() .48 .54
8 R=NY121B
)6TA+X#)8 .64 .60 .69
9 U4R=N+@3!:FPZ5 .56 .58
10 R=NU4)S&) .44 .38 .50
11 R=NG,Q(7)R=NS&) .57 .53
AGFI RMSEA SRMR
original 11-item version .80 .13 .08
Schimmit's 6-item version .82 .15 .07
8-item version .85 .12 .07




Indicators of goodness of fit
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Table 3-2-2. Result of confirmatory factor analysis of the Japanese version of Acceptance and Action Diabetes Questionnaire 
 
 
original 11-item version Schimmit's 6-item version  8-item version
1 I try to avoid reminders of my diabetes. .64 .62 .58
2 I have thoughts and feelings about being diabetic that are distessing. b -.44
3 I do not take care of my diabetes because it reminds me that I have diabetes. .70 .77
4 I eat things I shouldn't eat when the urge to eat them is overwhelming. .44 .51
5 When I have an upsetting feeling or thought about my diabetes, I try to get rid of that feeling or thought. .64 .61 .62
6 I avoid taking or forget to take my medication because it reminds me that I have diabetes. .67 .73
7 I avoid stress or try to get rid of it by eating what I know I shouldn't eat. .48 .54
8 I often deny to myself what diabetes can do to my body. .64 .60 .69
9 I don't exercise regulary because it reminds me that I have diabetes. .56 .58
10 I avoid thinking about what diabetes can do to me. .44 .38 .50
11 I avoid thinking about diabetes because someone I knew died from diabetes. .57 .53
AGFI RMSEA SRMR
original 11-item version .80 .13 .08
Schimmit's 6-item version .82 .15 .07
8-item version .85 .12 .07




Indicators of goodness of fit
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Table 3-3. Correlation coefficients of the AADQ-J with other measures, means and standard deviations (SD) 
 
AADQ-J CES-D PAID SDSCA_Diet SDSCA_Ex SF-8_PCS SF-8_MCS HbA1c
AADQ-J -    -0.41**    -0.44**     0.37**     0.24**    0.29**     0.32**     -0.21**
Means 41.82 16.00 43.98 22.35 7.40 46.58 44.78 6.81
SD 7.42 9.21 14.40 6.71 4.09 7.77 7.86 0.82
Hypothesis       
    Note . AADQ-J = Japanese version of Acceptance and Action Diabetes Questionnaire, CES-D = The Center for Epidemiologic Studies Depression Scale,
PAID = The Problem Areas in Diabetes Treatment Satisfaction Questionnaire, SDSCA_Diet =  The Summary of Diabetes Self-Care Activities Measure subscale
of diet, SDSCA_Ex =  The Summary of Diabetes Self-Care Activities Measure subscale of exercise, SF-8_PCS = the Short Form-8 Health Questionnaire as a
physical component score, SF-8_MCS = the Short Form-8 Health Questionnaire as a mental component score, ** p  < .01
 60 
 
Figure 3-1. Total information for the Japanese version of Acceptance and Action Diabetes Questionnaire 
across trait estimates. Information is determined for each item at each trait value at each response threshold, 
where there are k-1 response thresholds (k = total number of response options). Total information is the sum 
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Ȉ3ȉĪĺǆŤOd[JFƴ­ǃíúȈSDSCA; Üă{, 2006ȉ 
 SDSCA1ȊOd[JFƴ­0ǾúDśã@íú*@kƫŹ-ȁsȈȋǻźȉ	ȊŦ¤-ȁ
sȈ3 ǻźȉ	Ȋƞ½#ȁsȈkƫŹ-ȁs=3Ŧ¤-ȁs0 5 ǻźȉ	Ȋǝ­Ȉ2 ǻźȉ	Ȋ
ƪòƳƒśãȈ2ǻźȉ	ȊĶƱƏŪȈ2ǻźȉ	Ȋ[SVJFȈ5ǻźȉ	ȊÉţȈÉţ0ĵ
Ţȉ	0 8níú>ŃĒA@Od[JFƴ­+A#ĪD 1 Š+Ȋ¼ǻź.' 7 ĪǮ0½
Ƽ*ÊƍDŒ9#ĂŠȃ5,Od[JFƴ­Dƴ-&)@+Dƀĺžƈ*1Ȋƞ½#
ȁs	ǝ­	0níúDŬ# 






Ȉ5ȉĪĺǆŤ SF-8 Health SurveyȈSF-8; Ƅ³iǩȄ, 2005ȉ 
 SF-81Ȋ®ėŹûǯǛ QOLDśã@íú*@ǒŅƧ	ȊĪôĀ©ŅƧiǒ	Ȋ
0ŵ7	Ȋ×ŹûĐ	ȊŘª	ȊƂūŘŅƧ	ȊĪôĀ©ŅƧiƑƃ	ȊĄ0û	0






œŶ0źń1 7.0%ĹŜ*@ȈĪĺƒîųâ, 2018ȉ 
 
3. ),+ 
 ǻźĿƽ*1Ȋǻź·ćŪǋDǠć#ĿƽDƴ-&#VCQD 1 7 Ŗ0íú*@#9ȊÛǻź
TNV.é)ǠćºƧ-ōǴ·ćaUdDŬ#VCQD 0ËáŃǚDĿƽ@#9ȊĝƕŹËá
ĻDƴ-&#ǿċ0Ŀƽ1ȊCronbach 0 α Ĥ.=@Źĥ½ċȊǻź·ćŪǋ.=@TNVčÖ
ǯĤ>Ŀƽ#ŃĒłĉÞþċDĿƽ@#9ȊĪĺǆŤ VCQD +ǯǛĎãA@łĉDśã
@{íú+0żǯĤDƎ#żǯ0ý0Õŝ1ȊȐrȐ< .20DüżǯȊ.20 ≦ȐrȐ< .40D





















1Ȋƌ 1Ëá0çpŨ1 71.10%ȈÏĵ 10.67ȉȊƌ 2Ëá0çpŨ1 6.35%ȈÏĵ 0.95ȉȊƌ 3Ëá
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 VCQD 0ËáĤD 1 .ęã)ȊĳìŖ.=@ĝƕŹËáĻDƴ&#+BȊ×)0ǻź1.71 
>.91+±-ËáǏƮǦDƀ#ȈTable 3-5ȉǙËá¼ǻź.¾=-ÿǺDp)?ȊVCQ






 ¼ǐÇƓ0öÒ+ńŝñD Table 3-6 .ƀVCQD+Od[JFƴ­.ǯ)1ȊSDSCAƞ½
#ȁs	+0Ǯ.rƅú0ŋ0żǯȈr = .44Ȋp < .01ȉȊSDSCAǝ­	+0Ǯ.üŋ0żǯȈr = .32Ȋ
p < .01ȉƀA#VCQD +ƒîųǯǛƭŵ.ǯ)1ȊPAID +0Ǯ.ü0Ǐ0żǯȈr = -.20, p 
< .01ȉDƀ#VCQD +ūŘ0ǐ.ǯ)1ȊSF-8ǒŹL_cjNKF	+0Ǯ.üŋ0żǯ
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Ȉr = .26, p < .01ȉȊƑƃŹL_cjNKF	+0Ǯ.üŋ0żǯȈr = .31, p < .01ȉDƀ#VCQD





 VCQD0Źĥ½ċDĿƽ#+BȊCronbach0 αĤ1 0.97*&#6#Ȋǻź·ćŪǋ.=
@TNVčÖİƟDĿƽ#+BȊŦċ-2 > 2 0Ǯ*ȃDƀ)?ȊøƐÍ0Ŧċ.
)ȊśãƑúȃ+ƀA#ȈFigure 3-2ȉ 
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Table 3-4. Item Response Theory parameter estimates for the Values Clarification Questionnaire for Patients with Diabetes 
 
 
a b 1 b 2 b 3 b 4 b 5 b 6
1 78@[=&Z:2UJA"WV(0
' 2.08 -2.14 -1.73 -0.99 -0.10 0.61 1.44
2 Bb!78@[=&"%(K& 2.19 -1.97 -1.57 -0.85 0.06 0.72 1.74
3 2UZ:;%`
!%78@[=&K& 1.70 -2.24 -1.58 -0.99 -0.06 0.54 1.42
4 78@[=&Z:$U	NK& 1.49 -2.40 -1.69 -1.07 -0.20 0.45 1.40
5 78@ 5M+,-.*#I 1.06 -2.03 -1.55 -0.70 0.31 1.10 2.03
6 78@ Z:C XcW?%Y)& 1.43 -2.09 -1.54 -0.80 0.18 0.87 1.86
7 78@[=&4<#%!H6\L&# 1.51 -1.94 -1.35 -0.46 0.48 1.33 2.26
8 OGUT178@[=	& 2.08 -1.94 -1.44 -0.73 0.26 0.80 1.94
9 78@[=&9S
#K& 1.96 -1.88 -1.36 -0.69 0.20 0.87 1.71
10 78@ $DSL4<S$
 1.63 -1.93 -1.38 -0.51 0.32 1.02 2.10
11 78@[=&F/R!<^)&#K& 2.07 -1.99 -1.38 -0.83 0.22 0.91 1.76
12 	
 1.65 -2.05 -1.59 -0.78 0.12 0.76 1.73
13 _>"EQ#%!378@[=&a1	& 2.02 -1.91 -1.41 -0.70 0.19 0.85 1.80
14 Z:$U	N78@[=	& 2.42 -1.82 -1.33 -0.65 0.10 0.59 1.55
15 78@[=&2U"Z:P!]
&#& 2.19 -1.68 -1.26 -0.64 0.20 0.89 1.92
Items
Item parameter estimatesa
   a Each of the b  parameters corresponds to a probability = 0.5 of choosing the response that is +1 from the subscript. The a  parameter is the slope at the location of all b parameters and corresponds to the item’s
ability to discriminate between individuals of different trait levels.
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2 Bb!78@[=&"%(K& .91 .83
3 2UZ:;%`
!%78@[=&K& .86 .74
4 78@[=&Z:$U	NK& .83 .69
5 78@ 5M+,-.*#I .73 .53
6 78@ Z:C XcW?%Y)& .82 .67
7 78@[=&4<#%!H6\L&# .83 .70





11 78@[=&F/R!<^)&#K& .90 .81
12 	
 .86 .73
13 _>"EQ#%!378@[=&a1	& .90 .80
14 Z:$U	N78@[=	& .92 .85
15 78@[=&2U"Z:P!]
&#& .91 .83
Items Factor loding Commonality
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Table 3-6. Correlation coefficients of the VCQD with other measures, means and standard deviations (SD) 
VCQD PAID SDSCA_Diet SDSCA_Ex SF-8_PCS SF-8_MCS CES-D HbA1c
VCQD -    -0.20**     0.44**     0.32**    0.26**     0.31**    -0.51** 0.04
Means 67.38 43.52 22.86 7.52 46.70 45.38 15.17 6.80
SD 17.29 14.45 6.41 4.05 8.20 7.90 8.94 0.82
Hypothesis       ×
    Note . VCQD =  Values Clarification Questionnaire for Patients with Diabetes, PAID = The Problem Areas in Diabetes Treatment Satisfaction Questionnaire,
SDSCA_Diet =  The Summary of Diabetes Self-Care Activities Measure subscale of diet, SDSCA_Ex =  The Summary of Diabetes Self-Care Activities
Measure subscale of exercise, SF-8_PCS = the Short Form-8 Health Questionnaire as a physical component score, SF-8_MCS = the Short Form-8 Health
Questionnaire as a mentalcomponent score, CES-D = The Center for Epidemiologic Studies Depression Scale, ** p  < .01
 74 
 
Figure 3-2. Total information for the Values Clarification Questionnaire for Patients with Diabetes across trait 
estimates. Information is determined for each item at each trait value at each response threshold, where there are k-
1 response thresholds (k = total number of response options). Total information is the sum of information across all 













































 ­ʃŋ1Ɠȵ+2ʎ1óč 15ʁǛ+Ɩŗ$ VCQD2ʎCronbach1ªů/?BÒÀ.¼ǙŰãŋF
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B,ǧC$


































































2. oPMH  
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»£Ǚ/2ʎŋÃʌ0 = Ǎŋʎ1 = Ĉŋʍʎã¦Ǖ1Ƃ







 ǵ 3 Yb`o+2ʎIQ[o]YsKem|gY©¯1ŸǦÐ1¬şj]FƓȵB$
<ʎŬȤ K-means ƫ/?BQzY]ÀƍFȬ.'$
QzY]ůFƧēB$<1ɡãĳŠƘ,*ʎ
ĚůğĳʌLog likelihoodʍʎɈƦŏüɪûƸʌAIC; Akaike's Information CriterionʍʎqKZŏüûƸɪʌBIC; 
Bayesian Information CriterionʍʎWy|aŏüɪûƸʌSBIC; Schwarz's Bayesian Information Criterionʍ
FǊ$
 



























-.39, p < .01ʍʎƨǗǃƪʌβ = -.19, p < .01ʍƂŐ/ļʀF*B,ǧC$
SDSCAȌã
$ʆ/ɲ*ʎįʋʌβ = 0.21, p < .01ʍʎŋÃʌβ = .18, p < .01ʍƂŐ/ļʀF*B,ǧ
C$
SDSCAɝÎ/ɲ*ʎįʋʌβ = .25, p < .01ʍƂŐ/ļʀF*B,ǧC$








 ǵ 2 Yb`o+2ʎǵ 1 Yb`o+ƂŐ.ɲɛȰ@C$cwRzmJ`Qc]/Ë*ʎIQ[
o]YsKem|gY©¯1ŸǦÐFǄǳāůʎś(ǿĢǔɲɛŠƘFŀģāů,Bɨò
ĬÀƍFȬ.'$ʌTable 3-7-2ʍ
"1ȆƎʎCES-D/ɲ*ʎįʋʌβ = -.20, p < .01ʍʎIQ[o]
Yʌβ = -.12, p < .01ʍʎsKem|gYʌβ = -.34, p < .01ʍʎ©¯1ŸǦÐʌβ = -.35, p < .01ʍ"C#
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CǄǳ*ļʀF*B,ǧC$
SDSCAȌã$ʆ/ɲ*ʎŋÃʌβ = .20, p < .01ʍʎ
IQ[o]Yʌβ = .30, p < .01ʍʎ©¯1ŸǦÐʌβ = .39, p < .01ʍ"C#CǄǳ*ļʀF*
B,ǧC$
SDSCAɝÎ/ɲ*ʎįʋʌβ = .16, p < .05ʍʎIQ[o]Yʌβ = .21, p < .01ʍʎ
sKem|gYʌβ = -.18, p < .05ʍʎ©¯1ŸǦÐʌβ = .28, p < .01ʍ"C#CǄǳ*ļʀF*
B,ǧC$
PAID/ɲ*ʎã¦Ǖ1ƂƼʌβ = .26, p < .01ʍʎIQ[o]Yʌβ = -.35, p < .01ʍʎ
sKem|gYʌβ = -.23, p < .01ʍ"C#CǄǳ*ļʀF*B,ǧC$
HbA1c/ɲ
*ʎIQ[o]Yʌβ = -.18, p < .01ʍ1:ļʀF*B,ǧC$
 
 











































Table 3-7-1. Results of simple linear regression model 
 
Variables β 95% CI p  value
CES-D
  Age −.39 [-.51, -.26] .00
  Sex .00 [-.13, .15] .92
  Illness duration -.11 [-.25, .03] .11
  Complication .13 [-.01, .26] .07
  Cessation of treatment -.19 [-.33, -.05] .01
Diet
  Age .21 [.08, .35] .00
  Sex .18 [.05, .32] .01
  Illness duration .02 [-.12, .32] .83
  Complication .02 [-.12, .16] .78
  Cessation of treatment .06 [-.08, .19] .43
Exercise
  Age .25 [.11, .38] .00
  Sex -.03 [-.17, .11] .63
  Illness duration .01 [-.13, .15] .86
  Complication -.11 [-.25, .03] .13
  Cessation of treatment .04 [-.01, .18] .55
PAID
  Age -.19 [-.32, -.05] .00
  Sex -.09 [-.23, .05] .19
  Illness duration -.01 [-.15, .13] .91
  Complication .30 [.17, .43] .00
  Cessation of treatment .01 [-.13, .15] .86
HbA1c
  Age .12 [-.01, .26] .08
  Sex -.14 [-.27, .00] .06
  Illness duration .12 [-.02, .26] .09
  Complication .09 [-.05, .23] .21
  Cessation of treatment .13 [-.01, .27] .06
Note . β  = standardised partial regression coefficient, Diet =  The Summary of
Diabetes Self-Care Activities Measure subscale of diet, Exercise =  The Summary
of Diabetes Self-Care Activities Measure subscale of exercise,  PAID = The
Problem Areas in Diabetes Treatment Satisfaction Questionnaire, CES-D = The
Center for Epidemiologic Studies Depression Scale
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Table 3-7-2. Results of multiple regression model 
 
 
Variables β 95% CI p  value
CES-D
  Age -.20 [-.30, -.10] .00
  Cessation of treatment -.08 [-.19, .02] .11
  AADQ -.12 [-.24, -.00] .04
  MAAS -.34 [-.45, -.22] .00
  VCQD -.35 [-.46, -.25] .00
Diet
  Age .10 [-.02, .23] .11
  Sex .20 [.08, .32] .00
  AADQ .30 [.16, .43] .00
  MAAS -.09 [-.23, .04] .18
  VCQD .39 [.26, .51] .00
Exercise
  Age .16 [.03, .29] .02
  AADQ .21 [-.13, .15] .01
  MAAS -.18 [-.33, -.04] .02
  VCQD .28 [.03, .29] .00
PAID
  Age -.05 [-.17, .06] .38
  Complication .26 [.14, .39] .00
  AADQ -.35 [-.48, -.22] .00
  MAAS -.23 [-.36, -.10] .00
  VCQD -.05 [-.17, .06] .40
HbA1c
  AADQ -.18 [-.34, -.02] .02
  MAAS -.09 [-.25, .06] .24
  VCQD .10 [-.04, .24] .17
Note. β = standardised partial regression coefficient, Diet =  The Summary of
Diabetes Self-Care Activities Measure subscale of diet, Exercise =  The Summary
of Diabetes Self-Care Activities Measure subscale of exercise,  PAID = The
Problem Areas in Diabetes Treatment Satisfaction Questionnaire, CES-D = The
Center for Epidemiologic Studies Depression Scale,
AADQ = The Acceptance and Action Diabetes Questionnaire, MAAS = The
Mindful Attention Awareness Scale, VCQD =  The Values Clarification
Questionnaire for Patients with Diabetes
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Table 3-8. Fit statistics of cluster derived via improved k-means cluster analysis. 
 
Number of Clusters Log likelihood AIC BIC SBIC
3 −2383.44 4806.89 4873.92 4810.55
4 −2379.04 4812.08 4902.58 4817.03
5 −2372.80 4813.61 4927.57 4819.84
6 −2373.96 4829.92 4967.35 4837.44
Note. Akaike's Information Criterion, BIC = Bayesian information criterion, SBIC = Schwartz Bayesian information criterion
 87 
 
Figure 3-3-1. Patterns of Acceptance, Mindfulness and Values by differences from the sample mean (Z-Score).  
Note. AADQ = The Acceptance and Action Diabetes Questionnaire, MAAS = The Mindful Attention Awareness 


































Figure 3-3-2. Patterns of Acceptance, Mindfulness and Values by differences from the sample mean (Z-Score).  
Note. AADQ = The Acceptance and Action Diabetes Questionnaire, MAAS = The Mindful Attention Awareness 

































Table 3-9. Means, standard deviations, and Holm /Post-hoc tests ANCOVA results 
Cluster 1
average






 (N = 38)
Cluster 4
values/high
 (N = 48)
Pairwise comparisons Cohen'd
CES-D 17.73 (0.92) 8.86 (0.98) 22.82 (1.22) 13.29 (1.08) average < values/low 0.67
all/high < average 1.18
all/high < values/low 1.85
all/high < values/high 0.59
values/high < average 0.59
values/high < values/low 1.26
PAID 47.28 (1.61) 35.56 (1.73) 46.56 (2.28) 44.32 (1.95) all/high < average 0.90
all/high < values/low 0.85
all/high < values/high 0.68
HbA1c 6.84 (0.10) 6.50 (0.10) 6.64 (0.14) 7.10 (0.12) all/high < values/high 0.77









































































BʌKamrad et al., 2014; Mayberry, Gonzalez, Wallston, Kripalani, & Osborn, 2013ʍ
ƈǥǱ/*=ʎSDSCA





































Ň.Ŋȕ>őŏ/ĚBIQ[o]YFƶēB$<1ŠƘ,*ʎŵƈȼǀ Acceptance and Action 
Diabetes QuestionnaireʌAADQʍɰǘC$ʌǥǱ 1-1ʍ
9$ʎǿĢǔƨǗ/ɲEB©¯1ŸǦÐFƶ





































` 4 _ Ecological Momentary Assessment 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 ¼ǫăƋ1 2 úǿĢǔŌȖ?4±ĭȖFĚɃ,$
ɣŜûƸ2ʎǥǱÔÊ¶1¼ǫăƋ/Óį

























































signal-contingent recordingsʎǥǱĚɃ,.BLl\e>¿Ƌ/ƽƻFĺ*Ţ* event-contingent 





















ʌ1ʍYd}Yʑŵƈȼǀ Profile of Mood States





ʌ2ʍŪʆƝƥʑEcological momentary assessment scale for appetite










































 Ɍ£ƭÎɪFƶēB$</ 3ɎŲç1Ëəĳȴ+BʌGT3X-BT, ActiGraphǩʍFǊ$
¸Ʈ>
ĠĘŽ.-1ýãFɵ*ʎ14 ŵɱɛȉ*ƶē$
10 Ǭɱɸ+ǹ¿C$ 3 Ɏ1ãȴËəĳ@
metabolic equivalentsʌMETsʍFŦēʎ"1c]FǰǹB,/?AƭÎĹĳÃ1ŽɱFƥ<B
,àȚ+B
ƈǥǱ+2ʎɌ£ƭÎɪ1O`drKd¯/ Freedson Adult VM3ʌ2011ʍ1I|U{
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Î1òǸFʎɡÁ.ʆȬÎʌ0 = Ll\e.ʎ1 = Ll\eAʍ,$
9$ʎƶēŽɱ








































































































Note . denotes variables present only in event-contingent recordingsrightafter meals





 2úǿĢǔŌȖ 20æ?4±ĭȖ 16æ@ǥǱØË1åŐŁ@C$ʌTable 4-2ʍ
14ŵɱ1 EMA
+2ʎGoogle Form1»ã/?A 2úǿĢǔŌȖ 2æʎ£ȿȤ/?A 2úǿĢǔŌȖ 1æʎ±ĭȖ 1
æFɵăʎ¹ 4254òǸFŁ$
"1&ʎsignal-contingent recordings1òǸ+2ʎ2úǿĢǔŌȖ¹
568òʌƂÍòǸǅ 75.13%, ƀĝ¯ 16.67%, ƀĆ¯ 100.00%ʍʎ±ĭȖ¹ 612òʌƂÍòǸǅ 91.07%, 
ƀĝ¯ 61.90%, ƀĆ¯ 100.00%ʍ+'$
Event-contingent recordings1ɉıŽòǸ+2ʎ2úǿĢǔŌ
Ȗ¹ 203òʌĮù 11.94 ± 1.22ò, ƀĝ¯ 11ò, ƀĆ¯ 14òʍʎ±ĭȖ¹ 200òʌĮù 12.50 ± 1.54
ò, ƀĝ¯ 10 ò, ƀĆ¯ 14 òʍ+'$
9$ʎʆǜÈòǸ+2ʎ2 úǿĢǔŌȖ¹ 676 òʌĮù 
39.76 ± 13.86, ƀĝ¯ 10ò, ƀĆ¯ 56òʍʎ±ĭȖ¹ 649òʌĮù 40.56 ± 11.16, ƀĝ¯ 27ò, ƀĆ
¯ 66òʍ+AʎʆǜĿ1òǸ+2ʎ2úǿĢǔŌȖ¹ 716òʌĮù 37.35 ± 12.33, ƀĝ¯ 13ò, ƀ




 PHQ-9/ɲ*ʎ2úǿĢǔŌȖ1ĮùŁƻ2 4.12 ± 3.94+Aʎ5ƻʌɏĳ1(Ǖǃʍ2 6æʎ
10ƻʌǶĳ@ɨĳ1(Ǖǃʍ2 1æ+'$







Tabe 4-2. Demographic data of study participants, and t-tests significant results 
 
  
Patients with type 2 diabetes (N=20) Healthy persons  (N=16) p  value
Age in years, M (SD ) 53.05 (9.59) 49.50 (8.20) .24
Gender: n (%) female 8 (40%) 11 (68%) .11
Marital status, n (%) .49
Single 2 (10%) 0 (0%)
Married 18 (90%) 16 (100%)
Body mass index in k/m2, M (SD ) 28.47 (6.82) 20.51 (2.86) .00
Diabetes duration years, M (SD ) 9.21 (8.75) -
HbA1c, M (SD ) 7.06 (0.60) -
Insulin, n (%) 0 (0%) -
Oral medication, n (%) 17 (81%) -
Diabetes complications, n (%) 0 (0%) -
 108 
























  Tension-anxiety 1.81 (0.68) 2.02 (1.03) 1.71 (0.77) 1.87 (0.75) 1.59 (0.50) 1.70 (0.53) 1.82 (0.92) 1.56 (0.60) 1.88 (1.06) 1.57 (0.68)
  Depression 1.68 (0.66) 1.80 (0.97) 1.62 (0.83) 1.62 (0.56) 1.57 (0.63) 1.49 (0.43) 1.65 (0.75) 1.49 (0.62) 1.71 (0.98) 1.54 (0.72)
  Anger-Hostility 1.72 (0.64) 1.93 (0.83) 1.61 (0.65) 1.78 (0.72) 1.59 (0.62) 1.52 (0.46) 1.64 (0.75) 1.45 (0.61) 1.77 (0.90) 1.54 (0.59)
  Vigor 4.11 (0.64) 3.94 (1.13) 4.19 (1.18) 4.59 (0.93) 4.29 (1.02) 3.86 (0.92) 3.97 (1.04) 4.10 (0.92) 4.11 (0.96) 3.86 (0.95)
  Fatigue 3.48 (1.18) 3.39 (1.31) 3.20 (1.50) 3.66 (1.37) 3.15 (1.01) 2.59 (0.85) 2.59 (0.91) 2.35 (0.86) 2.85 (1.06) 2.76 (1.09)
  Confusion 1.74 (0.80) 1.70 (0.73) 1.84 (0.81) 1.69 (0.66) 1.72 (0.70) 1.49 (0.46) 1.64 (0.84) 1.49 (0.77) 1.69 (0.98) 1.54 (0.83)
  Hunger 2.65 (0.88) 4.33 (1.37) 1.89 (0.90) 4.31 (1.17) 1.70 (0.60) 2.89 (0.77) 4.41 (1.32) 1.98 (0.77) 4.23 (1.48) 1.55 (0.52)
  Cravings 2.59 (0.96) 3.90 (1.57) 1.78 (0.81) 4.55 (1.42) 1.66 (0.52) 2.65 (0.69) 4.14 (1.47) 1.83 (0.54) 4.29 (1.47) 1.50 (0.56)
External factor
  Time (14:00-23:00) - -
  Eating out - -
  Social situation - -
Dietary lapses - 27.28% 22.28%














Tabe 4-3-2. Means, standard deviations, and t-tests significant results 

1 !#")E 3.31 (1.16) 3.75 (0.97) .29
2 7;2,WN 1:	H/ 1 4.53 (0.84) 4.58 (0.70) .84
3 <42,WN 1: 4.63 (0.83) 4.83 (0.39) .37
4 BDIO5!#")E%3 >M 4.21 (1.18) 4.58 (0.70) .27
5 !#")E 9 3.15 (1.02) 2.75 (0.45) .20
6 !#")E 2.32 (0.95) 2.58 (0.70) .37
7 !#")E$0	 2.90 (1.15) 3.17 (1.16) .52
8 !#"A&S. 3.58 (1.12) 3.17 (1.19) .35
9 !#"A& 2.11 (0.94) 2.17 (0.94) .86
10 !#"A&6)E 144VQF)E 3.53 (1.35) 3.33 (1.37) .70
11 !#"A&6)E 143))E 3.84 (1.02) 3.67 (1.23) .68
12 	
 4.08 (0.67) 4.47 (0.84) .19
13 2,WNJCP(X@TGL 3.74 (1.56) 3.92 (0.90) .69
14 !#")E4-?=*
 1.90 (1.00) 2.83 (0.94) .01
15 1)!#")EK6VUR 1.90 (0.99) 2.17 (0.58) .34
16 BD8VUR 1.80 (0.79) 2.25 (0.87) .15
17 P(X@'+ 	>M 3.52 (1.31) 3.42 (1.08) .80
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Table 4-4. Affects pre-meal internal and external factors (antecedent) have on dietary lapses (behavior) 
 
Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Stress -0.02 0.04 -0.43 .67 0.98 [0.92, 1.06] 0.04 0.03 1.53 .13 1.04 [0.99, 1.10]
  Tension-anxiety -0.14 0.13 -1.08 .28 0.87 [0.68, 1.11] 0.08 0.11 0.71 .48 1.08 [0.87, 1.35]
  Depression -0.22 0.15 -1.47 .14 0.81 [0.60, 1.08] 0.07 0.12 0.60 .55 1.08 [0.84, 1.37]
  Anger-Hostility -0.17 0.12 -1.34 .18 0.85 [0.66, 1.08] 0.19 0.11 1.67 .09 1.20 [0.97, 1.50]
  Vigor 0.46 0.12 3.74 .00 1.58 [1.24, 2.02] 0.11 0.11 0.97 .33 1.11 [0.90, 1.38]
  Fatigue 0.49 0.11 4.57 .00 1.63 [1.32, 2.01] 0.21 0.08 2.51 .01 1.23 [1.05, 1.45]
  Confusion 0.09 0.14 0.62 .54 1.09 [0.83, 1.43] 0.11 0.14 0.84 .40 1.12 [0.86, 1.46]
  Appetite 0.09 0.05 2.07 .04 1.09 [1.00, 1.20] -0.03 0.04 -0.73 .47 0.97 [0.90, 1.05]
  Hunger -0.03 0.08 -0.34 .73 0.97 [0.83, 1.14] -0.14 0.07 -1.89 .06 0.86 [0.75, 1.00]
  Cravings 0.34 0.09 3.88 .00 1.34 [1.18, 1.66] 0.05 0.08 0.64 .52 1.05 [0.90, 1.24]
External factor
  Time zone 0.18 0.17 1.06 .29 1.20 [0.86, 1.66] 0.74 0.23 3.22 .00 2.10 [1.34, 3.29]
  Eating out 1.32 0.56 2.37 .02 3.74 [1.26, 11.11] 0.72 0.35 2.09 .04 2.06 [1.04, 4.06]
  Social situation -0.44 0.38 -1.17 .24 0.64 [0.31, 1.35] 1.18 0.42 2.82 .00 3.25 [1.43, 7.37]
Multivariate model
Internal factor
  Vigor 0.48 0.13 3.75 .00 1.62 [1.26, 2.09] - - - - - -
  Fatigue 0.52 0.12 4.46 .00 1.68 [1.34, 2.11] 0.16 0.09 1.85 .06 1.18 [0.99, 1.40]
  Cravings 0.23 0.09 2.52 .01 1.26 [1.05, 1.52] - - - - - -
External factor
  Time zone - - - - - - 0.70 0.24 2.92 .00 1.26 [1.26, 3.23]
  Eating out 1.58 0.61 2.61 .01 4.86 [1.48, 15.91] 0.33 0.39 0.83 .41 1.38 [0.64, 2.98]
  Social situation - - - - - - 1.13 0.47 2.40 .02 3.10 [1.26, 3.30]
Note . Obs.  = observations
Patients with type 2 Diabetes [ N  = 17, Obs. = 459 ] Healthy persons [ N  = 15, Obs . = 533]
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Table 4-5. Relations between dietary lapses (behavior) and pre-post meal internal factors differences 
 
  
Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Δ Stress 0.03 0.04 0.85 .40 1.03 [0.96, 1.14] -0.04 0.03 -1.12 .26 0.96 [0.90, 1.03]
  Δ Tension-anxiety 0.04 0.12 0.37 .72 1.04 [0.83, 1.32] 0.03 0.11 0.24 .81 1.03 [0.82, 1.28]
  Δ Depression 0.21 0.15 1.43 .15 1.24 [0.92, 1.65] -0.12 0.14 -0.84 .40 0.89 [0.68, 1.17]
  Δ Anger-Hostility 0.09 0.11 0.88 .38 1.10 [0.89, 1.35] 0.06 0.12 0.50 .62 1.06 [0.84, 1.34]
  Δ Vigor -0.64 0.14 -4.74 .00 0.53 [0.40, 0.69] 0.31 0.11 2.86 .00 1.36 [1.10, 1.68]
  Δ Fatigue -0.41 0.11 -3.78 .00 0.66 [0.53, 0.82] -0.03 0.10 -0.28 .78 0.97 [0.80, 1.18]
  Δ Confusion -0.10 0.13 -0.81 .42 0.90 [0.70, 1.16] -0.07 0.12 -0.55 .58 0.94 [0.74, 1.18]
  Δ Appetite -0.10 0.04 -2.75 .01 0.90 [0.84, 0.97] 0.03 0.03 0.79 .43 1.03 [0.96, 1.10]
  Δ Hunger -0.10 0.07 -1.44 .15 0.91 [0.80, 1.04] -0.01 0.06 -0.21 .84 0.99 [0.87, 1.12]
  Δ Cravings -0.26 0.07 -3.71 .00 0.77 [0.67, 0.88] 0.12 0.07 1.73 .08 1.12 [0.98, 1.28]
Multivariate model
Internal factor
  Δ Vigor -0.58 0.14 -4.12 .00 0.56 [0.42, 0.74] - - - - - -
  Δ Fatigue -0.34 0.12 -2.91 .00 0.71 [0.57, 0.90] - - - - - -
  Δ Cravings -0.19 0.07 -2.58 .01 0.83 [0.72, 0.96] - - - - - -
Note . Obs . = observations
Patients with type 2 diabetes [ N  = 17, Obs . = 459 ] Healthy persons [ N  = 15, Obs . = 533]
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Table 4-6. Differences in the degree of BMI on pre-meal internal and external factors (antecedent) influences on dietary lapses (behavior) 
 
  
Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Vigor 0.38 0.15 2.50 .01 1.47 [1.09, 1.98] 0.57 0.21 2.76 .01 1.77 [1.18, 2.65]
  Fatigue 0.41 0.15 2.70 .01 1.50 [1.12, 2.02] 0.54 0.15 3.50 .00 1.73 [1.27, 2.32]
  Cravings 0.45 0.13 3.50 .00 1.57 [1.22, 2.03] 0.23 0.12 2.02 .04 1.26 [1.01, 1.58]
External factor
  Eating out 1.45 0.91 1.58 .11 4.26 [0.71, 25.60] 1.22 0.72 1.69 .09 3.37 [0.82, 13.79]
Multivariate model
Internal factor
  Vigor 0.43 0.16 2.69 .01 1.54 [1.12, 2.11] 0.63 0.21 3.02 .00 1.88 [1.25, 2.84]
  Fatigue 0.45 0.16 2.87 .00 1.56 [1.15, 2.12] 0.63 0.17 3.72 .00 1.88 [1.35, 2.63]
  Cravings 0.48 0.14 3.42 .00 1.61 [1.23, 2.11] 0.01 0.13 0.09 .93 1.01 [0.79, 1.30]
External factor
  Eating out 1.91 0.96 1.99 .05 6.74 [1.03, 44.20] 1.50 0.79 1.89 .06 4.47 [0.95, 21.09]
Note. BMI = body mass index, Obs.  = observations
High level of BMI [N  = 8, Obs.  = 187] Low level of BMI [N  = 9, Obs.  = 272]
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Table 4-7. Differences in the degree of BMI on relations between dietary lapses (behavior) and pre-post meal internal factors differences (short term consequences) 
 
Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Δ Vigor -0.73 0.20 -3.68 .00 0.48 [0.32, 0.71] -0.54 0.19 -2.94 .00 0.58 [0.40, 0.83]
  Δ Fatigue -0.44 0.16 -2.67 .01 0.65 [0.47, 0.89] -0.42 0.15 -2.81 .01 0.66 [0.49, 0.88]
  Δ Cravings -0.35 0.10 -3.44 .00 0.70 [0.58, 0.86] -0.16 0.10 -1.71 .09 0.85 [0.70, 1.02]
Multivariate model
Internal factor
  Δ Vigor -0.70 0.21 -3.32 .00 0.50 [0.33, 0.75] -0.48 0.19 -2.50 .01 0.62 [0.42, 0.90]
  Δ Fatigue -0.42 0.19 -2.24 .02 0.66 [0.50, 0.95] -0.35 0.16 -2.19 .03 0.70 [0.51, 0.96]
  Δ Cravings -0.32 0.11 -2.92 .00 0.72 [0.58, 0.90] -0.06 0.10 -0.59 .56 0.94 [0.79, 1.14]
Note. BMI = body mass index, Obs.  = observations
High level of BMI [N  = 8, Obs.  = 187] Low level of BMI [N  = 9, Obs.  = 272]
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Covariates Estimate 95% lower 95% upper p  value
Univariate model
    Dietary lapses 4.87 -0.64 10.38 .08
Multivariate model 
    Dietary lapses 5.72 1.09 10.35 .02
MVPA -0.09 -0.17 -0.02 .02
Stress 1.08 0.45 1.71 .00
Sleeping hours -1.94 -3.45 -0.44 .01
Note . Obs.  = observations, MVPA = moderate to vigorous intensity physical activity










 EMA/ÀƁŖŅ-Ǚ(ǭsignal-contingent recordings/ÀƁ)0ǭ2ÄƄçŤąƓ 568ÀǫĪ¥À






contingent recordings/ƻóĨÀƁ)0ǭ2ÄƄçŤąƓ 203ÀǫñÃ 11.94 ± 1.22À, ĩä 11À, 
ĩÍ 14ÀǬǭðƓ 200ÀǫñÃ 12.50 ± 1.54À, ĩä 10À, ĩÍ 14ÀǬ)
<ǭǧŪ 
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 EMA-:=ģðśňp/WlS0ǭǝéŖĸǈAĖ&"7ǭh`g 1AxÊ¦ǫwithin levelǬǭ
h`g 2AxǘìŢǫbetween levelǬ*(ǭagTh`gı-:<{p/ƩıAƢ,%"ĮųŽ










































 ´ƺ¿Ƈ/ƬǅƋƪǕAŵAADQ0ñÃýő 39.05 ± 7.78ǭMAAS0ñÃýő 62.18 ± 12.00ǭVCQD
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Table 4-7-1. Differences in the degree of acceptance on pre-meal internal factors (antecedent) influences on dietary lapses (behavior) 
 
  
Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Vigor 0.65 0.27 2.43 .02 1.92 [1.13, 3.26] 0.38 0.14 2.66 .01 1.46 [1.10, 1.93]
  Fatigue 0.12 0.15 0.75 .45 1.12 [0.83, 1.51] 0.75 0.16 4.66 .00 2.12 [1.54, 2.90]
  Cravings 0.23 0.13 1.70 .09 1.26 [0.97, 1.63] 0.41 0.12 3.39 .00 1.51 [1.20, 1.91]
Multivariate model
Internal factor
  Vigor 0.64 0.27 2.43 .02 1.90 [1.13, 3.20] 0.42 0.16 2.67 .01 1.52 [1.12, 2.07]
  Fatigue 0.19 0.16 1.22 .22 1.21 [0.89, 1.64] 0.83 0.17 4.81 .00 2.30 [1.63, 3.22]
  Cravings 0.13 0.13 1.00 .32 1.14 [0.88, 1.50] 0.30 0.13 2.30 .02 1.35 [1.05, 1.74]
Note. Obs . = observations
High level of diabetes acceptance [N  = 7, Obs.  = 220] Low level of diabetes acceptance [N  = 10, Obs.  = 249]
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Table 4-7-2. Differences in the degree of mindfulness on pre-meal internal factors (antecedent) influences on dietary lapses (behavior) 
 
Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Vigor 0.26 0.22 1.22 .22 1.30 [0.85, 1.99] 0.63 0.17 3.70 .00 1.88 [1.35, 2.62]
  Fatigue 0.02 0.15 0.15 .88 1.00 [0.76, 1.38] 1.03 0.21 4.84 .00 2.80 [1.85, 4.26]
  Cravings 0.33 0.17 1.98 .05 1.39 [1.00, 1.93] 0.40 0.13 3.09 .00 1.49 [1.16, 1.91]
Multivariate model
Internal factor
  Vigor 0.18 0.24 0.75 .45 1.20 [0.75, 1.90] 0.50 0.20 2.47 .01 1.66 [1.11, 2.47]
  Fatigue 0.13 0.17 0.76 .45 1.14 [0.82, 1.58] 0.94 0.23 4.13 .00 2.55 [1.64, 3.98]
  Cravings 0.30 0.18 1.67 .09 1.35 [0.95, 1.92] 0.20 0.16 1.29 .20 1.22 [0.90, 1.67]
Note. Obs.  = observations
High level of mindfulness [N = 8, Obs.  = 212] Low level of mindfulness [N  = 7, Obs.  = 170]
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Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Δ Fatigue -0.06 0.18 -0.35 .73 0.94 [0.66, 1.33] -0.67 0.16 -4.12 .00 0.51 [0.37, 0.71]
  Δ Cravings -0.07 0.10 -0.70 .48 0.93 [0.76, 1.14] -0.40 0.10 -4.02 .00 0.67 [0.55, 0.82]
Multivariate model
Internal factor
  Δ Fatigue -0.05 0.18 -0.26 .80 0.96 [0.67, 1.36] -0.61 0.17 -3.63 .00 0.54 [0.39, 0.75]
  Δ Cravings -0.07 0.11 -0.66 .51 0.93 [0.76, 1.15] -0.36 0.11 -3.39 .00 0.70 [0.57, 0.86]
Note. Obs . = observations
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,Dɩǔ 1ǒ 4Ǚ2ǞǤƺ~ly.v_Ȕų2ǣŴCɩAcceptance and Commitment TherapyɧACTɨ
3Ș2 3 *2ȟɢIȔƊ-ErdYx}IǊ>,E.ǆF&µ ƺ13ɩ*ƵIÛ
¢,0 2 òǝēƵķǴIĎȥ.,ɩǂťɏëĄǣ2SYzbpħġ-ÆŴI,E
ɧGregg et al., 2007ɨ;&ɩACT-3ɩúƹĵǄÊƶɧSheppaard et al., 2010ɨɩƠɠƷɧDindo et al., 2012; 
Dindo et al., 2014ɨɩǷƘɧLillis et al., 2009ɨɩȉǘƴķɧDindo et al., 2015aɨ1Ď,ɩǂťɏëĄǣ
























































































ɧ1ɨŠůȜơ Acceptance and Action Diabetes QuestionnaireɧAADQ; ǃǏ 1-1-¡ńɨ 
 145 








ɧ3ɨValues Clarification Questionnaire for Patients with DiabetesɧVCQD; ǃǏ 1-2-¡ńɨɫǝēƵƋƸ1
ɐ E¦«2ţǅÊIƗą EĒĠ-E15 ɟƼ-ŻńF,Dɩ1ɫ#J#JĦ,3;C0
C7ɫ*?Ħ,3;E2 7Ǝ-ëǖIƉ>&Ĭƛɥ:/ǝēƵƋƸ1ɐ E¦«2ţǅ
Ê2ǌĠɥ.Iǆ  
ɧ4ɨŠůȜơ Patient Health Questionnaire-9ɧPHQ-9; ŰŲė, 2009ɨɫŊ*ƶƤIƗą EŏŽ-
E9ɟƼ-ŻńF,Dɩ0ɫ³01ɫśŠ2ɫÍ¸3ɫ:.J/ƆŠ2 4
Ǝ-ëǖIƉ>&9 ɟƼ2ÛȖĬƛ 5 ƛȱĠ2*ƶƤɩ10 ƛǕĠCɆĠ2*
ƶƤ.ąǰF,E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7. `D%c 
 ǃǏ 2-1.Ýż1ɩĥĠȭ ƐÇ.ɥĥĠȭ ƐÇIÛǗɩ1Š2ɥĥĠȭ ƐÇɧmoderate 
to vigorous intensity physical activity ; MVPAɨťɏɧ¸ɨIǗ·&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ǱŠ2øś2ƗɨIŷȗ&ª¶2ibfS¸ų-3ɩcontemporaneous network . temporal 
network2 2*2we}1BDɩøśù22³,2øś2ĨɞIǤ¾,ɩ$F%F2øśɏ2ɐ

























IƥǑøś. E°ɅǬ¸Ś¸ųIȊ)&;&ɩCohenɧ1998ɨ 2 Cohen’dIƫ,ɩÆŴɈIǗ·
ɩd = .20IĐ0ÆŴɈɩd = .50IǌĠ2ÆŴɈɩd = .80Iû0ÆŴɈ.& 
 ǝēƵɐȺŏŽ2Œǋɫ²ÁĪ1EÚǝēƵɐȺŏŽɧ1Š2ĜñT}V[«ɩ1Š2ĥĠ
ȭ ƐÇťɏɩ1Š2Ɂ¹0ɣȊÇ2ɡĠɩ1Š2Ĝñƺ[f~[ɨ2ŒǋIŷȗ E&>ɩǤȖȔų
^nf R 2 scdhlm kbUZ1ó+,ɩɕĖǪħwe}1BEÆŴɈ2Ǘ·IȊ)&ɧValentine, 
Tanner-Smith, Pustejovsky, & Lau, 2016ɨF3ɩABɧABɨƎ1ó+,ķǴªƆ1Ɖ>&²ÆŴ
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Iɩs}a~q}Ȕų-ɘȖ,ÓÃǴ³ -2²ÆŴ2ûIƉ>EȔų-EBetween-case 
standardized mean difference estimatorɧBC-SMDɨIƫ,ɩBC-SMD = .20IĐ0ÆŴɈɩBC-SMD = .50









































 2òǝēƵķǴ 8ÞCǃǏÓÃ2ÝļĬCF&ɧTable 5-1ɨ 
 ²Á2 14Šɏ2 EMA 1BEŠěƪƐȠŵ-3ɩ³ 986ëǖIĬ&$2(ɩsignal-contingent 
recordings 2ëǖ3ɩ³ 268 ëɧũÆëǖƦ 79.76%ɨ-)&ķǴ.2ũÆëǖƦIǅț&.
GɩID 1ɧũÆëǖƦ 90.48%ɨ, ID 2ɧũÆëǖƦ 97.62%ɨ, ID 3ɧũÆëǖƦ 33.33%ɨ, ID 4ɧũÆë
ǖƦ 54.76%ɨ, ID 5ɧũÆëǖƦ 88.10%ɨ, ID 6ɧũÆëǖƦ 95.24%ɨ, ID 7ɧũÆëǖƦ 57.14%ɨ, ID 
8ɧũÆëǖƦ 100.00%ɨ-)&Event-contingent recordings2ȨĞťëǖ3ɩ³ 100ëɧĜñ 12.50 ± 
1.07ɨ-)&;&ɩɣƽÁëǖ3ɩ³ 289ëɧĜñ 36.12 ± 7.23ɨ-DɩɣƽĪëǖ3ɩ³ 326ë
ɧĜñ 40.75 ± 10.55ɨ-)&ķǴ.2ëǖśIǅț&.GɩID 1ɧȨĞť 13ë, ɣƽÁ 39ë, 
ɣƽĪ 35ëɨ, ID 2ɧ13ë, ɣƽÁ 27ë, ɣƽĪ 54ëɨ, ID 3ɧȨĞť 11ë, ɣƽÁ 24ë, ɣƽĪ 24
ëɨ, ID 4ɧȨĞť 12ë, ɣƽÁ 34ë, ɣƽĪ 30ëɨ, ID 5ɧȨĞť 13ë, ɣƽÁ 44ë, ɣƽĪ 43ëɨ, 
ID 6ɧȨĞť 13ë, ɣƽÁ 41ë, ɣƽĪ 53ëɨ, ID 7ɧȨĞť 13ë, ɣƽÁ 38ë, ɣƽĪ 42ëɨ, ID 8
ɧȨĞť 14ë, ɣƽÁ 42ë, ɣƽĪ 45ëɨ-)& 
 ²Ī2 14Šɏ2 EMA 1BEŠěƪƐȠŵ-3ɩ³ 948ëǖIĬ&$2(ɩsignal-contingent 
recordings 2ëǖ3ɩ³ 264 ëɧũÆëǖƦ 78.57%ɨ-)&ķǴ.2ũÆëǖƦIǅț&.
GɩID 1ɧũÆëǖƦ 90.48%ɨ, ID 2ɧũÆëǖƦ 76.19%ɨ, ID 3ɧũÆëǖƦ 30.95%ɨ, ID 4ɧũÆë
ǖƦ 26.19%ɨ, ID 5ɧũÆëǖƦ 100.00%ɨ, ID 6ɧũÆëǖƦ 95.23%ɨ, ID 7ɧũÆëǖƦ 83.33%ɨ, ID 
8ɧũÆëǖƦ 100.00%ɨ-)&Event-contingent recordings2ȨĞťëǖ3ɩ³ 102ëɧĜñ 12.75 ± 
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0.89ɨ-)&;&ɩɣƽÁëǖ3ɩ³ 273ëɧĜñ 34.12 ± 6.59ɨ-DɩɣƽĪëǖ3ɩ³ 309ë
ɧĜñ 38.62 ± 11.46ɨ-)&ķǴ.2ëǖśIǅț&.GɩID 1ɧȨĞť 13ë, ɣƽÁ 31ë, 
ɣƽĪ 27ëɨ, ID 2ɧȨĞť 13ë, ɣƽÁ 25ë, ɣƽĪ 40ëɨ, ID 3ɧȨĞť 12ë, ɣƽÁ 33ë, ɣƽ
Ī 41ëɨ, ID 4ɧȨĞť 11ë, ɣƽÁ 25ë, ɣƽĪ 19ëɨ, ID 5ɧȨĞť 13ë, ɣƽÁ 40ë, ɣƽĪ 38
ëɨ, ID 6ɧȨĞť 13ë, ɣƽÁ 40ë, ɣƽĪ 56ëɨ, ID 7ɧȨĞť 13ë, ɣƽÁ 39ë, ɣƽĪ 48ëɨ, 








Table 5-1. Demographic data of study participants 
 
  
Age in years, M (SD )
Gender: n (%) female
Marital status, n (%)
Single
Married
Body mass index in k/m2, M (SD )
Diabetes duration years, M (SD )
HbA1c, M (SD )
Insulin, n (%)
Oral medication, n (%)
Diabetes complications, n (%)
8 (100%)
0 (0%)




































  Tension-anxiety 1.43 (0.47) 1.42 (0.46) 1.26 (0.39) 1.53 (0.53) 1.35 (0.54) 1.47 (0.62) 1.59 (0.73) 1.36 (0.43) 1.85 (1.16) 1.46 (0.77)
  Depression 1.34 (0.42) 1.32 (0.41) 1.27 (0.42) 1.46 (0.48) 1.30 (0.49) 1.41 (0.54) 1.46 (0.44) 1.31 (0.45) 1.61 (0.82) 1.44 (0.78)
  Anger-Hostility 1.58 (0.48) 1.60 (0.50) 1.36 (0.41) 1.70 (0.74) 1.42 (0.50) 1.51 (0.49) 1.52 (0.43) 1.41 (0.43) 1.85 (0.93) 1.62 (0.73)
  Vigor 4.07 (1.05) 4.06 (1.12) 4.21 (1.30) 4.44 (0.97) 4.32 (1.03) 3.82 (1.09) 3.69 (1.17) 3.95 (1.19) 4.12 (0.97) 4.24 (1.04)
  Fatigue 2.36 (1.10) 2.25 (1.01) 2.10 (1.00) 2.59 (1.19) 2.47 (1.09) 2.64 (1.31) 2.55 (1.27) 2.30 (1.24) 2.93 (1.39) 2.66 (1.29)
  Confusion 1.44 (0.61) 1.41 (0.55) 1.37 (0.52) 1.47 (0.68) 1.42 (0.58) 1.40 (0.56) 1.36 (0.47) 1.30 (0.46) 1.60 (0.81) 1.50 (0.76)
  Hunger 3.87 (1.74) 3.90 (1.78) 1.29 (0.34) 4.06 (1.33) 1.33 (0.40) 2.23 (0.97) 3.72 (1.85) 1.54 (0.55) 4.36 (1.19) 1.77 (0.67)
  Cravings 3.73 (1.82) 3.70 (1.85) 1.27 (0.35) 4.01 (1.50) 1.31 (0.36) 2.18 (0.93) 3.62 (1.97) 1.57 (0.55) 4.34 (1.14) 2.03 (0.72)
External factor
  Time (14:00-23:00) - -
  Eating out - -
  Social situation - -
Dietary lapses - 24.00% 11.06%
2.35% 7.54% 9.50% 8.33%
6.47% 5.66% 4.50% 13.88%
Baseline Treatment











































































































































































Figure 5-1-1.  Personalized contemporaneous network modeling for ID 1 to ID 4 in baseline 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. PPG = postprandial blood glucose, 
Time = time (14:00 to 23:00) 
       
 164 
 
Figure 5-1-2. Personalized contemporaneous network modeling for ID 6 to ID 8 in baseline 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. PPG = postprandial blood glucose, 
Time = time (14:00 to 23:00) 
          
 165 
 
Figure 5-2-1. Personalized contemporaneous network modeling for ID 1 to ID 4 in baseline 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. MVPA = moderate to vigorous 
intensity physical activity 
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Figure 5-2-2. Personalized contemporaneous network modeling for ID 6 to ID 8 in baseline 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. MVPA = moderate to vigorous 
intensity physical activity 
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Figure 5-2-3. Personalized temporal network modeling for ID 1 to ID 4 in baseline 
 Circles (nodes) represent variables and links denote that one variable predicts another variable in the next window 
of measurement. Solid links indicate positive relationship, broken links indicate negative relationship, and the width 
of links indicate the strength of the relationship. Note. MVPA = moderate to vigorous intensity physical activity 
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Figure 5-2-4. Personalized temporal network modeling for ID 6 to ID 8 in baseline 
 Circles (nodes) represent variables and link denotes that one variable predicts another variable in the next window 
of measurement. Solid links indicate positive relationship, broken links indicate negative relationship, and the width 
of links indicate the strength of the relationship. Note. MVPA = moderate to vigorous intensity physical activity 
  




  l}Ã)8ŉĥ*ŁŔĨĿŞ<ĚůTable 5-2Ű 
 >AGTH^FůAADQŰ)"	$+ű~sē({&$űl}*Ã%¥{ĺ69űfĝ»
*ìŞæË)Ě9ůCohen's d = -0.61, p < .05Ű/űÉį&)ÕĜ<ęŃ&: ID 1, ID 
3, ID 5, ID 6, ID 7, ID 8%+űl}*Ã%¥{ĺ69űID 2%+űl}Ã%ÿ³{ĺ
69 
 V@^NS[PFůMAASŰ)"	$+ű~sē({&$űl}*Ã%¦+ĺ69(!
ůCohen's d = -0.02, p = n.s.Ű/űÉį&)ÕĜ<ęŃ&: ID 3, ID 5%+űl}*Ã%¥
{ĺ69űID 1, ID 2, ID 6, ID 7%+űl}*Ã%¦ĺ69űID 8%+űl}Ã%
ÿ³{ĺ69 
 vy*áęůVCQDŰ)"	$+ű~sē({&$űl}*Ã%¦+ĺ69(!ůCohen's 
d = 0.19, p = n.s.Ű/űÉį&)ÕĜ<ęŃ&: ID 5, ID 6%+űl}*Ã%¥{ĺ











Table 5-2. Mean and standard deviation of AADQ, MAAS, VCQD and PHQ-9 in baseline and treatment 
  
Baseline Treatment d p  value
AADQ, M (SD) 39.86 (7.29) 44.28 (6.75) -0.61 .03
  ID 1 40 44
  ID 2 47 44
  ID 3 40 46
  ID 4 48 uncollected
  ID 5 50 56
  ID 6 28 35
  ID 7 35 38
  ID 8 39 47
MAAS, M (SD) 64.71 (16.71) 66.00 (16.46) -0.02 .90
  ID 1 69 67
  ID 2 75 76
  ID 3 62 66
  ID 4 58 uncollected
  ID 5 72 82
  ID 6 34 36
  ID 7 55 54
  ID 8 86 81
VCQD, M (SD) 78.71 (19.64) 75.14 (18.71) 0.19 .52
  ID 1 59 61
  ID 2 90 75
  ID 3 66 49
  ID 4 89 uncollected
  ID 5 100 105
  ID 6 57 78
  ID 7 74 67
  ID 8 105 91
PHQ-9, M (SD) 3.38 (5.76)
  ID 1 3
  ID 2 0
  ID 3 0
  ID 4 4
  ID 5 0
  ID 6 17
  ID 7 3
  ID 8 0
Note. AADQ = The Acceptance and Action Diabetes Questionnaire, MAAS = The Mindful












































)ÕĜ<ĔĻ%ęŃ&:űID 1, ID 2, ID 3, ID 4, ID 6, ID 7%+űl}* 2H`W%5
(Q
H`^ĺ69űID 8 %+űl}* 2 H`W%č(8QH`^ĺ69~sē)+űìŞ
 172 
+Ě9ůBC-SMD = -0.06, 95% Cl = -0.29 to 0.16Űűl}* 2H`W%5
(QH`^ĺ69
8&ęŃ9ò)űl}ůbaselineŰ* 14Þš&l}ÃůtreatmentŰ* 14Þš)$űl}
ì<îŀÉį&)ÕĜ<ĔĻ%ęŃ&:űID 1, ID 4, ID 6, ID 8%+űl}*Ã%ÿ
³{ĺ69űID 2, ID 3%+űl}*Ã%¦ĺ69űID 7%+űl}Ã%¥{
ĺ69~sē)+űl}*Ã%ÿ³{ĺ69ű²(ìŞæË)Ě9ůBC-SMD = -
0.24, 95% Cl = -0.51 to -0.02Ű/űHbA1c7.0ob*Éį*0ůID 1, ID 4, ID 6, ID 8Ű<±Ň&¤
%+űl}*Ã%ÿ³{ĺ69űfĝ»*ìŞæË)Ě9ůBC-SMD = -0.55, 95% Cl = -
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ůbaselineŰ* 14Þš< 2H`W)$ű5
(QH`^ĺ698*<îŀÉį&)
ÕĜ<ĔĻ%ęŃ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(QH`^ĺ69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69űID 1, ID 3, ID 4, ID 5, ID 6, ID 8%+űl}*Ã%¦ĺ69űID 7%+űl}*Ã%
ÿ³{ĺ69~sē)+űl}*Ã%¦+ĺ69(!ůBC-SMD = 0.08, 95% Cl = -0.09 
 173 
to 0.26ŰHbA1c7.0ob*Éį*0ůID 1, ID 4, ID 6, ID 8Ű<±Ň&¤%3űl}Ã%¦+ĺ




 l}Ã)81 Þ*dś(ŬĶ*Ū»*ÕĜ<ĚůFugure 5-3-3Űå)űl}é
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(QH`^
ĺ69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~sē)+űì
Ş+Ě9ůBC-SMD = 0.16, 95% Cl = -0.25 to 0.58Űűl}* 2H`W%5
(QH`^ĺ6
98&ęŃ9ò)űl}éůbaselineŰ* 14Þš&l}ÃůtreatmentŰ* 14Þš)$ű
l}ì<îŀÉį&)ÕĜ<ĔĻ%ęŃ&:űID 5, ID 6, ID 8%+űl}*Ã%ÿ³
{ĺ69űID 1, ID 2, ID 3, ID 4, ID 7%+űl}*Ã%¦ĺ69(!~sē)+ű
l}*Ã%ÿ³{ĺ69ű²(ìŞæË)Ě9ůBC-SMD = -0.47, 95% Cl = -0.75 to -
0.20Ű6)űHbA1c7.0ob*Éį*0ůID 1, ID 4, ID 6, ID 8Ű<±Ň&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ęŃ9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Éį&)ÕĜ<ĔĻ%ęŃ&:űID 1, ID 4%+űl}*Ã%ÿ³{ĺ69
űID 2, ID 3, ID 5, ID 7, ID 8, ID 8%+űl}*Ã%¦ĺ69űID 6%+űl}*Ã%¥{
ĺ69~sē)+űl}*Ã%¦+ĺ69(!ůBC-SMD = -0.10, 95% Cl = -0.28 to 0.07Ű
HbA1c7.0ob*Éį*0ůID 1, ID 4, ID 6, ID 8Ű<±Ň&¤%3űl}*Ã%¦+ĺ69(






)ĖŢůr = .-15, p = n.s.Ű+Ń269(!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Figure 5-3-2. Transition of day-to-day moderate vigorous physical activity time (minutes) 
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Figure 5-3-3. Transition of day-to-day dietary lapses 
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Figure 5-3-4. Transition of day-to-day stress 
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Table 5-3. Investigation of treatment effects on pre-meal internal factors influences on dietary lapses 
 
  
Estimate SE z p  value OR 95% CI Estimate SE Z p  value OR 95% CI
Univariate model
Internal factor
  Vigor 0.47 0.19 2.52 .01 1.60 [1.11, 2.32] 0.35 0.27 1.31 .19 1.42 [0.84, 2.38]
  Fatigue 0.70 0.17 4.16 .00 2.01 [1.45, 2.79] 0.14 0.18 0.77 .44 1.15 [0.81, 1.64]
  Cravings 0.26 0.13 2.01 .04 1.30 [1.01, 1.68] 0.23 0.16 1.50 .14 1.26 [0.93, 1.71]
Multivariate model
Internal factor
  Vigor 0.43 0.20 2.20 .03 1.54 [1.05, 2.27] 0.39 0.29 1.38 .17 1.48 [0.84, 2.60]
  Fatigue 0.70 0.18 3.79 .00 2.10 [1.40, 2.27] 0.21 0.21 1.02 .31 1.23 [0.82, 1.85]
  Cravings 0.12 0.15 0.81 .42 1.12 [0.85, 1.50] 0.20 0.17 1.18 .24 1.22 [0.88, 1.69]
Note. Obs . = observations
Baseline [N  = 8, Obs.  = 220] Treatment [N  = 8, Obs.  = 236]
 181 




Estimate SE z p  value OR 95% CI Estimate SE z p  value OR 95% CI
Univariate model
Internal factor
  Δ Fatigue -0.47 0.20 -2.35 .02 0.63 [0.42, 0.93] 0.15 0.23 0.65 .52 1.16 [0.74, 1.83]
  Δ Cravings -0.13 0.12 -1.15 .25 0.88 [0.70, 1.10] 0.00 0.15 -0.01 .99 1.00 [0.75, 1.34]
Multivariate model
Internal factor
  Δ Fatigue -0.44 0.20 -2.19 .03 0.64 [0.43, 0.95] 0.15 0.24 0.66 .51 1.17 [0.74, 1.85]
  Δ Cravings -0.08 0.12 -0.70 .49 0.92 [0.73, 1.16] -0.02 0.15 -0.10 .92 0.98 [0.73, 1.32]
Note. Obs . = observations
Baseline [N  = 8, Obs.  = 220] Treatment [N  = 8, Obs.  = 236]
 182 
13. $	 EMA  
 
ID 1̸Ų̷ 50Ȉ¨̺ľƖ̺BMI = 38.66̺HbA1c = 7.3̹ 







ID 2̸Ų̷ 50Ȉ¨̺ȽƖ̺BMI = 23.78̺HbA1c = 6.7̹ 
 ̭ƈʭɻÆh̸Figure 5-4-1̹3.̺ĵ̭D8ɞ«ɊȰȗ̀Û2̭ʯîKż






ID 3̸Ų̷ 60Ȉ¨̺ȽƖ̺BMI = 17.90̺HbA1c = 6.2̹ 
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 ̭ƈʭɻÆh̸Figure 5-4-1̹3. ̺̀Û2̭ʯîD8̭ƈ 2Ǖ̑ʭɻɬÚÆ3ƅ
̤K.Gʷĝ6ɜH2+( 
 WZ_Æh̸Figure 5-5-1, Figure 5-5-2̹3.̺Ĳǂ̑5̑36̺̒˺6ɜH2+( 
 
ID 4̸Ų̷ 60Ȉ¨̺ȽƖ̺BMI = 22.03̺HbA1c = 7.6̹ 
 ưʇʭɻȥŋě˷/ĵH(03DF̺ʭɻÆ5hcǂóÚ3ə¿/2+((@̺̭ƈ
ʭɻÆh/6 ̺̭ƈ 2Ǖ̑ʭɻɬÚÆ5ĲǂK̖ĵ .ʾǬKʯ2+(¥Ðä0hɁ2
G(@̺ġʲ36ǀ.˃ˮ 2+(=(̺WZ_Æh6Ǹˁ/2+( 
 ̭ƈʭɻÆh3.̺̭ȡǠ̀Û2̭ʯîKżˤ .G0ɜH( 
 




ID 6̸Ų̷ 40Ȉ¨̺ľƖ̺BMI = 36.57̺HbA1c = 7.3̹ 
 ưʇʭɻȥŋě˷/ĵH(03DF̺ʭɻÆ5hcǂóÚ3ə¿/2+((@̺W
Z_Æh6Ǹˁ/2+( 
 ̭ƈʭɻÆh̸ Figure 5-4-2 3̹. ̺Ǖ̑Ů̀Û2̭ʯîKżˤ .F ̺
̀Û2̭ʯî6̭ƈ 2Ǖ̑ʭɻɬÚÆK̰@G0ɜH(=(̺̭ȡǠ6̀Û2̭
ʯî0̒˺ .2̺̭ƈ 2Ǖ̑ʭɻɬÚÆ0̒˺ .G0ɜH(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ID 7̸Ų̷ 40Ȉ¨̺ľƖ̺BMI = 21.24̺HbA1c = 6.7̹ 
 ưʇʭɻȥŋě˷/ĵH(03DF̺ʭɻÆ5hcǂóÚ3ə¿/2+((@̺W
Z_Æh6Ǹˁ/2+( 




ID 8̸Ų̷ 60Ȉ¨̺ȽƖ̺BMI = 22.84̺HbA1c = 7.6̹ 








Figure 5-4-1. Personalized contemporaneous network modeling for ID 1 to ID 3 in treatment 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. PPG = postprandial blood glucose, 
Time = time (14:00 to 23:00) 
           
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Figure 5-4-2. Personalized contemporaneous network modeling for ID 6 to ID 8 in treatment 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. PPG = postprandial blood glucose, 
Time = time (14:00 to 23:00) 
              
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Figure 5-5-1. Personalized contemporaneous network modeling for ID 1 to ID 3, ID 8 in treatment 
 Circles (nodes) represent variables and links indicate partial correlations between variables in the same window of 
measurement, after controlling for all other variables in the same window of measurement and all variables of the 
previous window of measurement. Solid links indicate positive relationship, broken links indicate negative 
relationship, and the width of links indicate the strength of the relationship. Note. MVPA = moderate to vigorous 
intensity physical activity 

 
            
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
Figure 5-5-2. Personalized temporal network modeling for ID 1 to ID 3, ID 8 in treatment 
 Circles (nodes) represent variables and link denotes that one variable predicts another variable in the next window 
of measurement. Solid links indicate positive relationship, broken links indicate negative relationship, and the width 
















 =#̺EMA 5ĜɴȰȗ3̒ .̺¥Ðä5 14 ǋ̑5 EMA 3DGǋůȸȚˏǲ3.̺signal-
contingent recordings5Ĝɴ6̺Ñ 268Ĝ̸ǞìĜɴȳ 79.76%̹/+(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Ðƈ5 14ǋ̑5 EMA 3DGǋůȸȚˏǲ3.A̺ĉǾ5ĜɴȰȗʸEH(HE50
E̺Ĝɴ5NjqN_6Ǽ4ƭ¿H.(0ʕEHG & .̺ˢėɿƊȩ5ƷɧE̺ɖǕ
̑ĜňʄƂŻ5ƎȷʯîɊNvd3D+. N̺Vavc_̸ AADQ 6̹ċ"GÊċʸEH(
 {̺Pjtm_̸ MAAS 0̹ºÆ5Ǐəð̸ VCQD 6̹ĲðʸEH30ɜH(ȯ3̺
VCQD 6¥Ð3D+.Ɗȩ¯"GʖAś22+(HE5ȩ3̒ .̺NVavc_6̺
ɻŞɄƙʖ30+.ǆĺ2ʯîɊva_/F Ĳ̺ð5´Ĥķ+(0ʕEHGƠ̄3̺
¥Ðƈ5vW}3̒"GNXi/A ʞ̺Ú/Zi/2A5̸ ƕʕBƟƛ 0̹Zi
/GA5̸ atXNʯî ̹G0÷˚3ȉ+(0˃˴ʵǂʸEH(& . {̺
Pjtm_5ȥŋ36̺MAAS Kȹ.(̺MAAS 6Ȍ-0șƝ5ȯƖKïƯ (
A5K{Pjtm_5ǴǼƔ0 .®ʏ-.G̸Bear & Ryan, 2003̹Ȍ-0șƝ
K̰@.(@̺MBSR̻MBCT/6̺8˻̑5vW}3è.̺ǋ5ɔƜ˂ʌKŌ˩ .
ƏʷG0HG50E̺ɖǕ̑ĜňʄƂŻ/6 ̺Ȍ-0șƝ5ȯƖK̰@G3
ʟE2+(0ʕEHG=( V̺CQD5Ɗȩ¯ (56 º̺Æ5ǏəðKƩ+(0/ &̺5º
Æ3ċ(@5ğ̠Ɲ˕ðH(ăʜƖG50E̺VCQD 5Ɗȩ6̺ɎʊɊ3Įè













 ID 1̸Ų̷ 50Ȉ¨̺ľƖ̺BMI = 38.66̺HbA1c = 7.3̹3̒ .̺ˢėɿƊȩ5ƷɧE̺NVavc
_5ɨŸċ .G̺{Pjtm_0ºÆ5Ǐəð5ɨŸ36ĲðʸEH2+(ɻ
ŞɄ̒˺Ʊǿ3̒ .6̺1ǋ5űĦWZ_Æ1ǋ5űĦɊ_i_5ȣśʸEH(¥















 ̺ʞE5ºÆ̸ ÇŹ3̎ȸ .Őǉ0ǻ ȸȚK˶G̹3ċ(@̺ǌǡ3lWKʯ̺
̰ƀŸ˫²ȚîKʈư .0Kɍǿ0 (  2E ̺1ǋ5̰ƀŸ˫²ȚîǕ̑6
Įè (A55̺¥Ðƈ36̺HE5̒˺6ɜH22+(&5ȷȻ0 .̺Ñ²Ɋ31ǋ5
̰ƀŸ˫²ȚîǕ̑Įè (0/̺ǋ057E,Ś2F̺1 ǋ5űĦWZ_Æ
05̒˺ʸEH22+(ăʜƖGHE5ʄǮE̺ID 2 6¥ÐĻç 2+(X_/
G0G() I̺D 2/6̺̰ƀŸ˫²Țî̊5ʈưɍǿ/+((@̺ɍǿʞ²6˿ƦH
(0G 






ÚÆK̰@.G0Kė̫0 .ÓǞ ǌ̺ǡ5¯ʭɻKʕƤ 2E Ĵ̺̭Ǖ/62ṷ̌Ǖ3
.̺̭Ɏä5ƕʕBƟƛ̸ȯ3ȚȌBɃë̹3Ȍ-BșƝKċ.̺̭:G_s
jB̊KʸɎ ̺ƟK¸+.̭:G0Kɍǿ0 (& .̺¥Ðƈ36̺HE5̒¼ʸEH2










Kė̫0 .ÓǞ ̺ǌǡ3˦Ē5ǁȇK 2E̺đĠ5ǖʣ3Ȍ-BșƝKċ.̺Ɵ
K¸+.ǖʣKĒJ+.>G0Kɍǿ0 (  2E̺ưʇʭɻȥŋě˷/ĵH(03
DF̺¥Ðƈ5Ĳð6əˋ/2+(HE5ʄǮE̺ID 4 6¥ÐĻç (X_5ăʜƖ6
G 











̭ʯî3Gƅ̤¯ȣ (0ʕEHGHE5ʄǮE̺ID 5 6¥ÐĻç (X_5ă
ʜƖG 
 ID 6̸Ų̷ 40Ȉ¨̺ľƖ̺BMI = 36.57̺HbA1c = 7.3̹3̒ .̺ˢėɿƊȩ5ƷɧE̺NVavc
_0ºÆ5Ǐəð5ɨŸċ .G̺{Pjtm_5ɨŸ36ĲðʸEH2+(ɻ
ŞɄ̒˺Ʊǿ3̒ .6̺1 ǋ5űĦɊ_i_6Įè .F̺1 ǋ5̰ƀŸ˫²ȚîǕ̑
36ĲðʸEH2+(̺1ǋ5űĦWZ_Æ1ǋ5̀Û2̭ʯî5̩Ÿ5ȣśʸ




/G̺Ō˩ .>G0Kɍǿ0 (& .̺¥Ðƈ36̺HE5̒˺ʸEH22+(0
əˋH(50E̺ɘɭ 2-2/ƊEH(ɕʸ5˸F̺NVavc_ċ"G0/̺ÖɊ
ʷĝ̸ȯ3Ƀë̭ȡǠ̹̀Û2̭ʯî3Gƅ̤¯ȣ ̺1ǋ5űĦWZ_
Æ5ȣśʸEH(0ʕEHG  2E̺Ǖ̑Ů̭ȡǠ̭ƈ 2Ǖ̑ʭɻɬÚÆ
K̰@.G0ɜH.F̺ʞʻH.2 ̺̀Û2̭ʯîˤ.Gị̆Gă
ʜƖAɜĖH(HE5ʄǮE̺ID 66¥ÐĻç (X_/G0G 
 ID 7̸Ų̷ 40Ȉ¨̺ľƖ̺BMI = 21.24̺HbA1c = 6.7̹3̒ .̺ˢėɿƊȩ5ƷɧE̺NVavc
_5ɨŸ6ċ .G̺{Pjtm_5ɨŸ36ĲðʸEH#̺ºÆ5Ǐəð5ɨŸ6¯
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GD32+(0AʕEHGHE5ʄǮE̺ID 7 6¥ÐĻç 2+(X_/G0
G 




c3Ī-Na_~i5ʄǮE ̺Ǖ̑Ů̭ƈ 2Ǖ̑ʭɻɬÚÆ0̒˺ .G0Kė
̫0 .ÓǞ ̺ǡ̭ṷ̌Ǖ3.̺̭Ɏä5ƕʕBƟƛ3Ȍ-BșƝKċ.̺̭:G
_sjB̊KʸɎ ̺ƟK¸+.̭:.>G0Kɍǿ0 (& .̺¥Ðƈ36̺HE5̒¼
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ʸEH22+(0əˋH(50E̺EMAhc3Ī-Na_~iʄǮKÓǞ 
(03DF̺̭ ʯî5atlcW½˼H(0/ ̺̭ƈ 2Ǖ̑ʭɻɬÚÆ¯ȣ ̺





0ɜH.(¹7̺Houtveen et al.̸ 2015̹/6̺̈Ÿ5˫²ʲȶƖ̜ŏ 9ĊKŘ˚0 .̺4˻
̑3J(F EMA3DGǋůȸȚˏǲKʯ̺×˅̸ʦɆŸBɃë̹0ȌÚ5̒˺KǸˁ (&5ʄ
Ǯ̺Ñ²Ɋ36z^gOuƛî0mUgOuƛî5Ǉ ×̺˅̸ ʦɆŸBɃë̹0̒˺ .G0
ɜH(̺&5̒˺6Ã¢03ķɁ2+.G0ɜH(¹7̺Gƙʖ/6̺×˅
̸ʦɆŸBɃë̹0mUgOuƛî5̑36̢ů3ƀȅ5ɏ̸̒r = .99̹ɜH.(̺Þ5ƙʖ
/6̺žȅ5ɏ̸̒r = .17̹/G0ɜH(=(̺Stavakakis et al.̸2015̹/6̺ƪ,
ÊċʖKŘ˚0 .̺30 ǋ̑3J(F EMA 3DGǋůȸȚˏǲKʯ̺˫²Țî̊0ȌÚ5̒˺K






 ©5ʄǮK=0@. Table 5-53ɜ"ìǮʸEH(̄Ú6
̺ìǮ;0L1ʸEH2+(̄
Ú6	̺ìǮʸEH2+(̄Ú65˃ĄK§(¥ÐĻç (X_6 3 ¹̸ID 1, ID 6, ID 
8̹̺¥ÐĻç (ăʜƖ5GX_6 2¹̸ID 4, ID 5̹̺¥ÐĻç 2+(X_6 3¹̸ID 
2, ID 3, ID 7̹/+(¥ÐĻç (X_̸ID 1, ID 6, ID 8̹̺G6¥ÐĻç (ăʜƖ5
GX_̸ID 4, ID 5̹3.̺¥Ðva_5ƛĬK¹Ȋ5hcEǸˁ (0I̺ EMA
hc5tOjoeV3DG̭ʯî3Ř"GatlcW5½˼̸ID 1, ID 8̹̺ NVavc
_5ċ3DG_i_ʭɻÆ3ý<"ƅ̤5¯ȣ̸ID 4̹̺ NVavc_5ċ3DG̭ʯ
î_V5¯ȣ̸ID 5, ID 6̹̺5 3ȩ¥Ðva_5ȯƍ0 .ʕEH(&H'H3,.̺1
5D2ƙʖ3Ř .ìǮʸEH(5̺EMAhc3Ī-Na_~i5ʽȩEʕŕKʯ(
 
 =# ̺ EMAhc5tOjoeV3DG̭ʯî3Ř"GatlcW5½˼̸ ID 1, ID 8̹




ìǮKǸˁ .F̺&5ìǮɜH.G¹7̺Kramer et al.̸2014̹/6̺,ɄƙʖKŘ˚
0 .̺6˻̑3J(F EMA3DGǋůȸȚˏǲKʯ̺Ȋ˻̺Ã¢03z^gOuƛî5Ĳîp
cKtOjoeV"G05ìǮǸˁH(&5ʄǮ t̺OjoeVKʯ2+(ʑ/6 t̺
OjoeVKʯJ2+(ʑ0ȋ˭ .̺atlcW½˼HG0/̺¥Ðƈ 6 ǝ5
Ǖȩ/ƪ,ɅȰǞƝ3¯ .G0ɜH(Ǧɘɭ5ʄǮE̺ÖɊĵɊʷĝ̀Û
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  NVavc_5ċ3DG_i_ʭɻÆ3ý<"ƅ̤5¯ȣ̸ID 4̹3̒ .̺¥Ðä5W
Z_Æh3.̺1ǋ5űĦɊ_i_1ǋ5űĦWZ_Æ0̒˺ .(5
6̺ID 4)/62̺ID 3, ID 6, ID 7, ID 83.AʸEH.(  2E̺¥Ð3D+._
i_¯ȣ (56 I̺D 45>/+(() ̺HE5ƙʖ3.A̺NVavc_ċ"
G0/ _̺i_ʞ²6¯ȣ .2 &̺5ƅ̤æĲð .(ăʜƖ6ʕEHGƠ̄3̺
ID 3, ID 8/6̺¥Ðƈ5WZ_Æh3.̺1ǋ5űĦɊ_i_01ǋ5űĦWZ
_Æ5̒˺ʸEH22+.GHE50E ɻ̺ŞɄȕɇ3¬Ɠ2ƕʕBƟƛ3Ř"
G̒JFǇĲð (0/̺Əʷ3_i_KĮè$G0ś22F̺ʭɻZi
ƾę (ăʜƖ6G̺ID 4, ID 6, ID 7/6̺¥Ðƈ5WZ_ÆhKǸˁ"G0/2
+((@̺¤ƈE2GǸˁƏʷ/G 
  NVavc_5ċ3DG̭ʯî_V5¯ȣ̸ID 5, ID 6̹3̒ . I̺D 50 ID 6/6̺¥Ðä
5̭ƈʭɻÆh3.̺ȋ˭Ɋʵ̟2meiVɜH.(0E̺̭ʯî3ė̫KƬ
.Gƙʖ/+(0Gɘɭ 2-25ʄǮE̺NVavc_6̺Ƀë̭ȡǠ5_V
K¯ȣ"G0ɜH.( ¥̺Ð3D+.NVavc_ċ"G0/ Ơ̺̄3 ̺HE5_
V¯ȣ"G0ɜH(0GHE50E̺̭ ʯî3ė̫KƬ.Gƙʖ3Ř . N̺
Vavc_6Ǟȹ/G0ʕEHG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AADQ MAAS VCQD EMA assessment Glucose MVPA Dietary lapses Stress
ID 1        
ID 2 ×  × ×    
ID 3   ×     
ID 4        
ID 5        
ID 6        ×
ID 7   ×  × ×  
ID 8  × ×     
Number of
effectiveness 6 2 2 6 4 1 3 2
     Note.  AADQ = The Acceptance and Action Diabetes Questionnaire, MAAS = The Mindful Attention Awareness Scale, VCQD =  The Values
Clarification Questionnaire for Patients with Diabetes, MVPA = moderate to vigorous intensity physical activity
Process Outcome
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2+(ɘɭ 2-25ʄǮE Ö̺Ɋʷĝ5Ĳð3DGƅ̤Kž@G(@36 º̺Æ5ǏəðK̰@G0
5̈ʷƖɜĖH.(̺Ǧɘɭ/6̺ºÆ5Ǐəð3ĲðʸEH.23AJE# ̺Ƀ











 Ǧɯ3.̺ACT 5ʯîɊva_3ȫȩKƁ.(¥Ð0 .̺ɖǕ̑ĜňʄƂŻ5ƎȷʯîɊ
NvdKŌǈ &̺5ìǮǸˁH(Ǧɘɭ5üèʖ36 ƪ̺,Êċ5¯ƙʖĶǂď=H
.F ¥̺Ð5ʄǮ ś̺20A¥Ðƈ 2ǝ5Ǖȩ3.̺ŋ5ìǮɜH(50E̺
Ɖǩ5ƎȷɇȘɊ¥Ð5ˎ̸̫ Ř˚5̔ŋð ̺¥ÐǕ̑Bëæ5ķ K̹ʾȓ ƊGăʜƖɜĖ
H(E3̺EMA3DF̺g~Pj5Na_~iK˼@̺ʭɻZi3ƅ̤K
.GʷĝK Ã̺Þ5ƙʖ03ĉŋ"G0/ &̺5ƙʖǜAĀFʂ>B" ̺,¥ÐvW}
5ìǮƊEH&2ɍǿK˄ŋ"G00A3̺¥Ð3ʢþƒKɜ"ƙʖ0&5¥Ðva_5ȯƍ
KǏE3 .0ǸˁH(&5ʄǮ ¥̺Ðva_5ȯƍ0 . ̺ EMAhc5tO
joeV3DG̭ʯî3Ř"GatlcW5½˼̺ NVavc_5ċ3DG_i_









 ǜƈ3Ǧɘɭ5̔Ⱦ0¤ƈ5ŠǠ3,.˴:Gɲ 13 ¥̺Ðƈ5ǋůȸȚˏǲ3. ư̺ʇʭ
ɻȥŋě˷/ĵH. =ƙʖʵǂĊÙ.F̺WZ_Ĳî5hcȣ+. =+(0
G&5ȷȻ0 . ¥̺Ðƈ5ǋůȸȚˏǲ5ǕǢɑĳ/+((@ Ɉ̺Ȑ213DFưʇʭɻ
ȥŋěĵHB"+(ăʜƖG=( Ǧ̺ɘɭ/ȹ(ưʇʭɻȥŋě6 »̺ʶƖ¯0ɜ
H.G ƙ̺ʖ3˛ƭƟ2+(06ʿÛH2¤ƈ6 ̺HE5ȩ3ȿƝ .ɘɭKʯƏ
ʷG 
 ɲ 23̺Ǧɘɭ6 t̺O^rgO_chO0 .5Ẹ̀ƀ+((@̺ɘɭh\P0 . ʅ̺
àʑK˄ʏ .2+(0GǦɘɭ6 ś̺ǂ¹Ō̯h\P5 ABȘ3Ī-.ƙʖÃ¢Ȋ
3ȏ@(¥Ðäƈ/5ɻŞɄ̒˺Ʊǿ5ĲðK̺̙šʊƂh̸Valentine et al., 2016̹3D+.ĆǕǢ
5ǕɼÜhc5ijAèĒ (/̞ˀ üèʖÑ²/ìǮ̊Kȏ@GʾǬKʯ+.F̺&5




5ìǮKȱɮ .Ǹˁ .0AƏʷ/G0ʕEHG 
 ɲ 4 3̺¥Ð/5×2cYei6̭ɶȷ/F̺˾î215¦atXNʯî3̒ .6óÚ3
Ʃ2+(0GƠ̄3̺1ǋ5̰ƀŸ˫²ȚîǕ̑3̒ .̺¥Ð5äƈ/ĲðʸE
H2+(¤ƈ6 ¥̺Ð/5×2cYeiK˾î3 (ĭć5¥ÐìǮKǸˁ .ƏʷG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 ɲ 5 3̺̎ǢɊʄǮ5Ǹˁ6̺Ķ5Íʯɘɭ0ĉǾ3̺¥Ðƈ 3 ǝ©Ö3ȿ=+.G0
G¤ƈ6̺E3ˏǲKʆʇ .ʯ̺Ɖǩ5ƎȷɇȘɊ¥Ð5ˎ̸̫̎ǢɊìǮ̹Kʾȓ/G5
KǸˁ .ƏʷG 
 ɲ 63̺üèʖ5¢ǂ 8Ċ0śǂ/+(0G&5(@̺̞Ğx5ǜ̀ð "̺2J*̺
yi}Nev3¥Ðva_5hcKʪɬ .0/ȘãŋɮɊ2ʡðK˼@.̺0
ȩ3̒ . {̺dxÚǬKʯ0/ &̺H'H5ƙʖ/ʸEH(¥Ðva_5Êċ Ñ̺²5
Êċ0 .AɜH.GA55 ó̺Ú3Ǹˁ/.G06ʿ̠ (+. ̺HE5Êċ
̄5ƙʖ5>3ʸEHG5 ƙ̺ʖÑ²3ˋ@EHG56Ǐ/G¤ƈ6 [̺v[P`KĮB
 2E̺E3hcKʪɬ .0/̺5ȩKǸˁ .0ȏ@EHG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 Ǧɸ/6̺Ǧɘɭ3.ɜH(ʄǮ3,.Ǽʽ ǃ̺ȷ"G=#ɲ 1ɯ/6̺ɻŞɄƙʖ3Ř
"GƎȷɇȘɊ¥Ð5ɘɭîċ3,.Ǽʽ (0I̺ƎȷɇȘɊ¥Ð5ƏʷƖˋ˕H.F̺
ŋ5ìǮɜH.G3A̒JE#̺ɻŞɄȕɇ3.óÚ3ȚȹH.25ȶȰ/G
0˴:EH(&5ȷȻ0 . ̺Ř˚ʖ5̔ŋð̺̎ǢɊìǮ ̺¥Ð3ʷ"GǕ̑Bëæ3̒
JGė̫ƲEH(&5D2̺˲ Ų/6 Ɖ̺ǩ5ƎȷɇȘɊ¥Ð06Ɂ2GNvd0 .̺
{Pjtm_0NVavc_5ǼƔKĀFÐH(ƎȷɇȘ̸Mindfulness- and Acceptance-Based 
Interventions; MABIs ̹șɍH.F ɲ̺ 4ɸ/6 M̺ABIs5ɼʅɊr0~cʾǬʯJH(




ºÆK˵ȏ"G(@3̺atXNʯîKġ+.̸Gregg et al., 2007̹  2E̺ACT5ʯî
Ɋva_̺Ô²Ɋ315D2ìǮK.G50ȩ6óÚ3ǸˁH.20Ʊ
ƼH( 




a_5ìǮKǸˁ .0̈ʷ/G0˴:EH(  2E̺ʯîÚǬŅɊhKŌ
ˇɊ3Ǹˁ .(@5ˎ̫0 .̺ˢėɿȘ5̔ȾƲEH(&/ Ǧ̺ɯ/6̺ˢėɿȘ5̔
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ɗ  Ħ. (1999). PAID (ɻŞɄę̫̇Ĩˢėʲ) Kȹ(ɻŞɄƙʖ5Ɵƛ˛ƭŸ5ȥŋ. ɻŞɄ, 42(1), 
S262. 
ɗ  Ħ. (2000). ȯ̞ ɻŞɄ5ƎȷɊ˒ė̫0&5{m^~i 1. ɻŞɄ5ƎȷʯîŅɊ˒ė̫. ɻ
ŞɄ, 43(1), 13-16. 
ɫȺ ÁįĈÖ Ȝ. (2013). 2 ħɻŞɄ3Ř"GƺŮƛĬɰǥKȹ(atXN]_g}5ăʜ
Ɩ. ʯîòŅɘɭ, 19(2), 64-67. 
Ismail, K., Winkley, K., & Rabe-Hesketh, S. (2004). Systematic review and meta-analysis of randomised controlled 
trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. The 
Lancet, 363(9421), 1589-1597. 
Jung, H. Y., Lee, H., & Park, J. (2015). Comparison of the effects of K orean mindfulness-based stress reduction, 
walking, and patient education in diabetes mellitus. Nursing & health sciences, 17(4), 516-525. 
 218 
Kabat-Zinn, J. (1990). Full catastrophe living: The program of the stress reduction clinic at the University of 
Massachusetts Medical Center. 
Kabat-Zinn, J. (2009). Wherever you go, there you are: Mindfulness meditation in everyday life. Hachette Books. 
Kamradt, M., Bozorgmehr, K., Krisam, J., Freund, T., Kiel, M., Qreini, M., ... & Ose, D. (2014). Assessing self-
management in patients with diabetes mellitus type 2 in Germany: validation of a German version of the 
Summary of Diabetes Self-Care Activities measure (SDSCA-G). Health and quality of life outcomes, 12(1), 185. 
èʬ ±¶̉ ǏłŢǦ ƞţǨ ̮ʎŚȝ ŉĈȺ ̴ʐŗŨ ʍÕ. (2011). 2 ħɻŞɄʖ3
GƎȷɊ˛ƭƟ0ȌÚȰơD8ƖǵÊċ05̒˺Ɩ3̒"GĪɛɘɭ. Ǝ˫òŅ, 51(8), 721-
730. 
Khashouei, M. M., Ghorbani, M., & Tabatabaei, F. (2016). The Effectiveness of Acceptance and Commitment 
Therapy (ACT) on Self-Efficacy, Perceived Stress and Resiliency in Type II Diabetes Patients. Global Journal 
of Health Science, 9(5), 18. 
Kikuchi, H., Yoshiuchi, K., Inada, S., Ando, T., & Yamamoto, Y. (2015). Development of an ecological momentary 
assessment scale for appetite. BioPsychoSocial medicine, 9(1), 2. 
Kopf, S., Oikonomou, D., Hartmann, M., Feier, F., Faude-Lang, V., Morcos, M., ... & Nawroth, P. P. (2014). Effects 
of stress reduction on cardiovascular risk factors in type 2 diabetes patients with early kidney disease–results of 
a randomized controlled trial (HEIDIS). Experimental and Clinical Endocrinology & Diabetes, 122(06), 341-
349. 
 219 
Kramer, I., Simons, C. J., Hartmann, J. A., Menne-Lothmann, C., Viechtbauer, W., Peeters, F., ... & van Os, J. (2014). 
A therapeutic application of the experience sampling method in the treatment of depression: a randomized 
controlled trial. World Psychiatry, 13(1), 68-77. 
Kristeller, J. L., & Wolever, R. Q. (2011). Mindfulness-based eating awareness treatment (MB-EAT): Conceptual 
basis. Eating Disorders: The Journal of Treatment Ö Prevention, 19, 49-61. 
Lillis, J., Hayes, S. C., Bunting, K., & Masuda, A. (2009). Teaching acceptance and mindfulness to improve the lives 
of the obese: A preliminary test of a theoretical model. Annals of Behavioral Medicine, 37(1), 58-69. 
Mayberry, L. S., Gonzalez, J. S., Wallston, K. A., Kripalani, S., & Osborn, C. Y. (2013). The ARMS-D out performs 
the SDSCA, but both are reliable, valid, and predict glycemic control. Diabetes research and clinical 
practice, 102(2), 96-104. 
Miller, C. K., Kristeller, J. L., Headings, A., Nagaraja, H., & Miser, W. F. (2012). Comparative effectiveness of a 
mindful eating intervention to a diabetes self-management intervention among adults with type 2 diabetes: a 
pilot study. Journal of the Academy of Nutrition and Dietetics, 112(11), 1835-1842. 
Miller, C. K., Kristeller, J. L., Headings, A., & Nagaraja, H. (2014). Comparison of a mindful eating intervention to 
a diabetes self-management intervention among adults with type 2 diabetes: a randomized controlled 
trial. Health Education & Behavior, 41(2), 145-154. 
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and 
meta-analyses: the PRISMA statement. Annals of internal medicine, 151(4), 264-269. 
 220 
Ǩǫ Òʐłť Ģß. (2009). ʝŵɘɭ vP{XNˆɇ0,Ʉ_VlWˈºf--
Patient Health Questionnaire-9 ǋǦˌȮ I0E)5ˢėɡ 3,.. ˆǅ0ȕɇ, 97(7), 
1465-1473. 
Ȇʬ Ŧ̰Ȃ ɩ (2007). Ʀ¢5ƒȹʯîÚǬ――Sik3AʯîÚǬ 6¸G ķȔÖ Ȝ¢Ȇʬ Ŧ 
(ʋ) ʯîÚǬ, 69-78 |mMǛƧ. 
Neff, K. D., & Germer, C. K. (2013). A pilot study and randomized controlled trial of the mindful self-compassion 
program. Journal of clinical psychology, 69(1), 28-44. 
ǋǦɻŞɄŅ« (2018). ɻŞɄȕɇUPj ǄÎī. 
Norris, S. L., Engelgau, M. M., & Narayan, K. V. (2001). Effectiveness of self-management training in type 2 
diabetes: a systematic review of randomized controlled trials. Diabetes care, 24(3), 561-587. 
O’Donohue, W., Snipes, C., & Soto, C. (2016). A case study of overselling psychotherapy: An ACT intervention for 
diabetes management. Journal of Contemporary Psychotherapy, 46(1), 15-25. 
ķǧ ɾƌȺ ʤųÏȴ ̘ǨȺ ­. (2014). ȌÚƟƛȰơˈº0 .5 Visual Analogue Scale 
5ƒȹ. w_v]ȷŅɇȘɘɭ, 4(3), 137-141. 
ķş ʫłȆʬ Ŧ. (2011). ʘȦ5ƾę62%̠ 5: NVavc_ & Z|ei~ias
 (ACT) E5Ƹʿ. ƎȷʝŵɥŅ Doshisha Clinical Psychology: therapy and research, 1(1), 53-64. 
ķş ʫł (2017). ɲ 12 ɯ 2 ħɻŞɄ, ̡Ţ ˗̃Ȇʬ Ŧ̸ʋ̹ƎȷŅE>(̭:Gʯî : Īɛ
Eʝŵ=/KɥŅ"G, 53-64. ñķ˨ǛƧ 
Öst, L. G. (2014). The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-
analysis. Behaviour research and therapy, 61, 105-121. 
 221 
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Welch, G., Jacobson, A. M., Aponte, J. E., & Schwartz, C. E. (1995). 
Assessment of diabetes-related distress. Diabetes care, 18(6), 754-760. 
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing 
psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes care, 28(3), 626-631. 
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied 
psychological measurement, 1(3), 385-401. 
̶ʬ ̧Ǳú ʧʐ¶Ũ ķȁŤȺ Ƅ̮ǦȺ ǙķÖ ±łȭ̉ ŉǓ. (2017). ºÆ5Ǐəð
ŜŸ5µƦD8À̪Ɩ0ŀƁƖ5Ǹˁ, ʯîɇȘɘɭ, 43 (1), 15-26.  
̆  ʐǯȆʬ Ŧªʬ ʒƌ. (2011). {Pjtm_ˋɕɇȘ0 ACT	ɲ 3¨5ʯîɇȘK
ƭ 2¢5ɉŢŐ(*, Ȇʬ Ŧ̸ʋ̹ACTnjueV	ʝŵʯîÚǬ3DG{Pjt2Nv
d, 255-268. ǑēǛŷ. 
ĥ̉ ǡłȆʬ Ŧ. (2012). ºÆ5ȃʜ06³̼Ōˇ3Ī-ºÆɘɭ3,.5ŠǠ, Ǝȷʝŵ
ɥŅ Doshisha Clinical Psychology: therapy and research, 2 (1), 69-80 
°ʬ ǳł. (1992). ɻɄƙʖ3G̭ɇȘ5ʞŭˈº0ZsWʯî. ǋǦɐ˘ɥŅ«ˊ, 12(4), 19-
35. 
Schmitt, A., Reimer, A., Kulzer, B., Haak, T., Gahr, A., & Hermanns, N. (2014). Assessment of diabetes acceptance 
can help identify patients with ineffective diabetes self-care and poor diabetes control. Diabetic 
Medicine, 31(11), 1446-1451. 
Schroevers, M. J., Tovote, K. A., Keers, J. C., Links, T. P., Sanderman, R., & Fleer, J. (2015). Individual mindfulness-
based cognitive therapy for people with diabetes: A pilot randomized controlled trial. Mindfulness, 6(1), 99-110. 
 222 
Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2002). Mindfulness-based cognitive therapy for depression: A 
new approach to preventing relapse. New York, NY, US: Guilford Press. 
Shayeghian, Z., Hassanabadi, H., Aguilar-Vafaie, M. E., Amiri, P., & Besharat, M. A. (2016). A randomized 
controlled trial of acceptance and commitment therapy for type 2 diabetes management: the moderating role of 
coping styles. PloS one, 11(12), e0166599. 
Sheppard, S. C., Forsyth, J. P., Hickling, E. J., & Bianchi, J. (2010). A novel application of acceptance and 
commitment therapy for psychosocial problems associated with multiple sclerosis: Results from a half-day 
workshop intervention. International Journal of MS Care, 12(4), 200-206. 
Shiffman, S., Stone, A. A., & Hufford, M. R. (2008). Ecological momentary assessment. Annu. Rev. Clin. Psychol., 4, 
1-32. 
ť Ƙ̳ ̉ ˿ȽñǨ ¾ãț  ǎŽ. (1985). ǆ ƪ,ƖʞŭˈºŜŸ3,.. ɺɠòŅ, 27(6), 
717-723. 
Ƞȍ ʳį. (2016). t5ʅˀÚǬbti HAD: ȃʜ5ʁ¥0ʅˀŅʔƿʚ, ɘɭŌ˩3Gßȹ
ǇȘ5ƸǶ. 
Spook, J. E., Paulussen, T., Kok, G., & Van Empelen, P. (2013). Monitoring dietary intake and physical activity 
electronically: feasibility, usability, and ecological validity of a mobile-based Ecological Momentary 
Assessment tool. Journal of medical Internet research, 15(9). 
Stavrakakis, N., Booij, S. H., Roest, A. M., de Jonge, P., Oldehinkel, A. J., & Bos, E. H. (2015). Temporal dynamics 
of physical activity and affect in depressed and nondepressed individuals. Health Psychology, 34(S), 1268. 
 223 
Stone, A. A., & Shiffman, S. (2002). Capturing momentary, self-report data: A proposal for reporting 
guidelines. Annals of Behavioral Medicine, 24(3), 236-243. 
Stone, A. A., & Shiffman, S. (1994). Ecological momentary assessment (EMA) in behavorial medicine. Annals of 
Behavioral Medicine. 
Ū̵ Ƣĸ̃. (2011). ɻŞɄ95ˋɕʯîɇȘ (ȯ̞ nrg]5ìǮKGˋɕʯîɇ
Ș). Monthly book medical rehabilitation, 138, 59-64. 
Thomas, J. G., Doshi, S., Crosby, R. D., & Lowe, M. R. (2011). Ecological momentary assessment of obesogenic 
eating behavior: Combining person-specific and environmental predictors. Obesity, 19(8), 1574-1579. 
ɻŞɄhc{m^~iɘɭ«. http://jddm.jp 
ɻŞɄmeiV. http://www.dm-net.co.jp 
Tovote, K. A., Fleer, J., Snippe, E., Peeters, A. C., Emmelkamp, P. M., Sanderman, R., ... & Schroevers, M. J. (2014). 
Individual mindfulness-based cognitive therapy (MBCT) and cognitive behavior therapy (CBT) for treating 
depressive symptoms in patients with diabetes: results of a randomized controlled trial. Diabetes care, 
DC_132918. 
Tovote, K. A., Schroevers, M. J., Snippe, E., Sanderman, R., Links, T. P., Emmelkamp, P. M., & Fleer, J. (2015). 
Long-term effects of individual mindfulness-based cognitive therapy and cognitive behavior therapy for 
depressive symptoms in patients with diabetes: a randomized trial. Psychotherapy and psychosomatics, 84(3), 
186-187. 
˙Ⱥ ɣȁ (2012). ̦ɍþƒȷˑ[Ð̏ʋ](ɲ 2Ȯ) (ʅˀPu)  ǡÂǛŷ. 
 224 
Valentine, J. C., Tanner-Smith, E. E., Pustejovsky, J. E., & Lau, T. S. (2016). Between-case standardized mean 
difference effect sizes for single-case designs: a primer. Oslo, Norway: The Campbell Collaboration. 
van Son, J., Nyklíček, I., Pop, V. J., Blonk, M. C., Erdtsieck, R. J., Spooren, P. F., ... & Pouwer, F. (2013). The effects 
of a mindfulness-based intervention on emotional distress, quality-of-life, and HbA1c in outpatients with 
diabetes (DiaMind): a randomized controlled trial. Diabetes care, DC_121477. 
van Son, J., Nyklíček, I., Pop, V. J., Blonk, M. C., Erdtsieck, R. J., & Pouwer, F. (2014). Mindfulness-based cognitive 
therapy for people with diabetes and emotional problems: long-term follow-up findings from the DiaMind 
randomized controlled trial. Journal of psychosomatic Research, 77(1), 81-84. 
Wang, M. Y., Tsai, P. S., Chou, K. R., & Chen, C. M. (2008). A systematic review of the efficacy of non-
pharmacological treatments for depression on glycaemic control in type 2 diabetics. Journal of clinical 
nursing, 17(19), 2524-2530. 
Wegner, D. M., Schneider, D. J., Carter, S. R., & White, T. L. (1987). Paradoxical effects of thought 
suppression. Journal of personality and social psychology, 53(1), 5. 
Weingarten, H. P., & Elston, D. (1990). The phenomenology of food cravings. Appetite, 15(3), 231-246. 
Wierzbicki, M., & Pekarik, G. (1993). A meta-analysis of psychotherapy dropout. Professional Psychology: 
Research and Practice, 24(2), 190. 
ŢǦ ıɗ  ĦĂŐ ʐųţŧ ɘĸ̃˰  Ƙ. (2000). ɻŞɄƿʚƈƙʖ3G̭ɇȘŁ
ŏʷĝ5ʾǬ. ɻŞɄ, 43(4), 293-299. 
ŢÖ ɟÖȝ ùȺ Ɨł. (1989). ʘȦD8ʘȦħɻŞɄ3G̭ȸȚ (̭ʯî0Ǝ˫5o
_). Ǝ˫òŅ, 29(3), 251-260. 
 225 
ŇȺ è¨łǫţ ʉʬȺ ČƽĂ˟ Ǐʐ°ʬ ēł. (2005). ɻŞɄ5ʞŭɶȷ3GŘ¢̒¼
5ğ̠Ɩ―ğ̠2Ȍư*EʙŋɊ2Ȍư*90Ĳð (ŘØʯî. ǋǦɐ˘ɥŅ«ˊ, 25(2), 28-36. 
ȀŢ ē£. (1990). POMS (ƟƛvtOǸǲ) ǋǦˌȮ5µƦ0À̪ƖD8ŀƁƖ5Ǹˁ. ǋǦÒ
ʮʱȸ̟ˊ, 37(11), p913-918. 
Ĉǫ öÀ. (2004). ʘȦɅ5ʯîɇȘ. ɻŞɄ¨˔ɅÄʑ. Þ×òŅ5C>, 827-834. 
Yu, J. H., Shin, M. S., Kim, D. J., Lee, J. R., Yoon, S. Y., Kim, S. G., ... & Kim, M. S. (2013). Enhanced carbohydrate 
craving in patients with poorly controlled Type 2 diabetes mellitus. Diabetic medicine, 30(9), 1080-1086. 
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., ... & Suez, J. (2015). Personalized 





 ǦŅ®ˑǄĩɳ3(F̺Ķ5Ǉ3Ʊř̺ƽƹKˡF= (ɋǾ3ȟ˔ȼ =" 








="̢ ů3ĶƑ5̺ˑ ǄKŖ3əˋ() ź̺˄Ɋ2ƝʸKǂĶ()= (Í
ȸǇ5/̺ǦŅ®ˑǄKDFɚG0/(0Ɵ!.F="ǦƁ3F0
= ( 
 ×ǲ å̺ǲ5ÍȸǇ©ĵ3A Ķ̺5ÍȸǇ3ƽƹK()= (òɇȘ¢ɞĞ6B$«ñúò











 (Ǧɘɭ5˽ʯ36 Ķ̺5˞ȹƏʷ/+((@ ɘ̺ɭĽê˞5éƦ6ķĲF(Ɵ!.
F="5ĭKÅF.ɝȼ =" 
 ǜƈ3 Ǧ̺ɘɭ3õæ .)+(Ñ.5Ǉ3Ɵ˔Kȼ ="& . ɤ̺BF(0K
ǚʸņ+.H(ʼ3Ɵ˔ ="ɋǾǦƁ3F0= ( 
 
2019Ų 2ǝ 1ǋ 
̶ʬ ̧ 
